COVER
COVER - shares | 9 Months Ended | |
Dec. 31, 2022 | Feb. 02, 2023 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Dec. 31, 2022 | |
Document Transition Report | false | |
Entity File Number | 001-40508 | |
Entity Registrant Name | Doximity, Inc. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 27-2485512 | |
Entity Address, Address Line One | 500 3rd St. | |
Entity Address, Address Line Two | Suite 510 | |
Entity Address, City or Town | San Francisco | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 94107 | |
City Area Code | 650 | |
Local Phone Number | 549-4330 | |
Title of 12(b) Security | Class A common stock, $0.001 par value per share | |
Trading Symbol | DOCS | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | false | |
Entity Central Index Key | 0001516513 | |
Current Fiscal Year End Date | --03-31 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false | |
Common Class A | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 118,704,101 | |
Common Class B | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 74,886,344 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2022 | Mar. 31, 2022 |
Current assets: | ||
Cash and cash equivalents | $ 136,454 | $ 112,809 |
Marketable securities | 664,511 | 685,304 |
Accounts receivable, net of allowance for doubtful accounts of $700 and $359 at December 31, 2022 and March 31, 2022, respectively | 74,862 | 81,073 |
Prepaid expenses and other current assets | 17,120 | 19,439 |
Deferred contract costs, current | 5,572 | 5,512 |
Total current assets | 898,519 | 904,137 |
Property and equipment, net | 11,519 | 8,488 |
Deferred income tax assets | 40,338 | 48,558 |
Operating lease right-of-use assets | 14,357 | 1,087 |
Intangible assets, net | 33,034 | 7,909 |
Goodwill | 67,940 | 18,915 |
Other assets | 1,380 | 2,263 |
Total assets | 1,067,087 | 991,357 |
Current liabilities: | ||
Accounts payable | 1,604 | 463 |
Accrued expenses and other current liabilities | 33,151 | 25,270 |
Deferred revenue, current | 69,671 | 84,907 |
Operating lease liabilities, current | 1,458 | 642 |
Total current liabilities | 105,884 | 111,282 |
Deferred revenue, non-current | 140 | 78 |
Operating lease liabilities, non-current | 14,181 | 447 |
Contingent earn-out consideration liability, non-current | 15,625 | 0 |
Other liabilities, non-current | 1,083 | 956 |
Total liabilities | 136,913 | 112,763 |
Commitments and contingencies (Note 12) | ||
Stockholders' Equity | ||
Preferred stock, $0.001 par value; 100,000 shares authorized as of December 31, 2022 and March 31, 2022, respectively; zero shares issued and outstanding as of December 31, 2022 and March 31, 2022, respectively | 0 | 0 |
Class A and Class B common stock, $0.001 par value; 1,500,000 shares authorized as of December 31, 2022 and March 31, 2022, respectively; 193,252 and 192,398 shares issued and outstanding as of December 31, 2022 and March 31, 2022, respectively | 193 | 192 |
Additional paid-in capital | 745,506 | 702,589 |
Accumulated other comprehensive loss | (18,742) | (15,294) |
Retained earnings | 203,217 | 191,107 |
Total stockholders’ equity | 930,174 | 878,594 |
Total liabilities and stockholders’ equity | $ 1,067,087 | $ 991,357 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | Dec. 31, 2022 | Mar. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Accounts receivable, allowance for doubtful accounts | $ 700 | $ 359 |
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, authorized (in shares) | 100,000,000 | 100,000,000 |
Preferred stock, issued (in shares) | 0 | 0 |
Preferred stock, outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, authorized (in shares) | 1,500,000,000 | 1,500,000,000 |
Common stock, issued (in shares) | 193,252,000 | 192,398,000 |
Common stock, outstanding (in shares) | 193,252,000 | 192,398,000 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | ||||
Revenue | $ 115,262 | $ 97,876 | $ 308,086 | $ 249,895 |
Cost of revenue | 13,526 | 11,085 | 39,813 | 28,022 |
Gross profit | 101,736 | 86,791 | 268,273 | 221,873 |
Operating expenses: | ||||
Research and development | 20,519 | 16,225 | 58,645 | 44,926 |
Sales and marketing | 33,220 | 25,698 | 90,375 | 66,230 |
General and administrative | 9,513 | 9,079 | 26,986 | 25,102 |
Total operating expenses | 63,252 | 51,002 | 176,006 | 136,258 |
Income from operations | 38,484 | 35,789 | 92,267 | 85,615 |
Other income, net | 2,461 | 20 | 4,173 | 485 |
Income before income taxes | 40,945 | 35,809 | 96,440 | 86,100 |
Provision for (benefit from) income taxes | 7,477 | (19,838) | 14,290 | (31,957) |
Net income | 33,468 | 55,647 | 82,150 | 118,057 |
Undistributed earnings attributable to participating securities, basic | 0 | 0 | 0 | (21,866) |
Undistributed earnings attributable to participating securities, diluted | 0 | 0 | 0 | (21,866) |
Net income attributable to Class A and Class B common stockholders, basic | 33,468 | 55,647 | 82,150 | 96,191 |
Net income attributable to Class A and Class B common stockholders, diluted | $ 33,468 | $ 55,647 | $ 82,150 | $ 96,191 |
Net income per share attributable to Class A and Class B common stockholders: | ||||
Basic (in dollars per share) | $ 0.17 | $ 0.30 | $ 0.43 | $ 0.62 |
Diluted (in dollars per share) | $ 0.16 | $ 0.26 | $ 0.38 | $ 0.53 |
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders: | ||||
Basic (in shares) | 192,805 | 188,372 | 192,963 | 154,289 |
Diluted (in shares) | 212,065 | 216,396 | 213,656 | 182,905 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income | $ 33,468 | $ 55,647 | $ 82,150 | $ 118,057 |
Other comprehensive income (loss) | ||||
Change in unrealized gain (loss) on available-for-sale-securities, net of tax benefit (provision) of $(958), $1,347, $1,172, and $1,347, respectively | 2,817 | (3,238) | (3,448) | (3,992) |
Comprehensive income | $ 36,285 | $ 52,409 | $ 78,702 | $ 114,065 |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Statement of Comprehensive Income [Abstract] | ||||
Change in unrealized loss on available-for-sale-securities, tax benefit (provision) | $ (958) | $ 1,347 | $ 1,172 | $ 1,347 |
CONDENSED CONSOLIDATED STATEM_4
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands | Total | Class A and Class B Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Loss | Retained Earnings |
Beginning balance (in shares) at Mar. 31, 2021 | 76,287,000 | ||||
Beginning balance at Mar. 31, 2021 | $ 81,458 | ||||
Increase (Decrease) in Temporary Equity [Roll Forward] | |||||
Conversion of redeemable convertible preferred stock upon initial public offering (in shares) | (76,287,000) | ||||
Conversion of redeemable convertible preferred stock upon initial public offering | $ (81,458) | ||||
Ending balance (in shares) at Dec. 31, 2021 | 0 | ||||
Ending balance at Dec. 31, 2021 | $ 0 | ||||
Beginning balance (in shares) at Mar. 31, 2021 | 82,910,000 | ||||
Beginning balance at Mar. 31, 2021 | 66,743 | $ 83 | $ 30,357 | $ (21) | $ 36,324 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Stock-based compensation | 20,681 | 20,681 | |||
Exercise of stock options (in shares) | 8,536,000 | ||||
Exercise of stock options | 9,314 | $ 9 | 9,305 | ||
Vesting of restricted stock units (in shares) | 13,000 | ||||
Tax withholding on shares under stock-based compensation awards | (436) | (436) | |||
Repurchase and retirement of common stock (in shares) | (181,000) | ||||
Repurchase and retirement of common stock | (2,698) | (2,698) | |||
Common stock warrant expense | 1,269 | 1,269 | |||
Conversion of redeemable convertible preferred stock upon initial public offering (in shares) | 76,287,000 | ||||
Conversion of redeemable convertible preferred stock upon initial public offering | 81,458 | $ 76 | 81,382 | ||
Issuance of common stock upon initial public offering, net of offering costs (in shares) | 22,506,000 | ||||
Issuance of common stock upon initial public offering, net of offering costs | 548,452 | $ 22 | 548,430 | ||
Other comprehensive income (loss) | (3,992) | (3,992) | |||
Net income | 118,057 | 118,057 | |||
Ending balance (in shares) at Dec. 31, 2021 | 190,071,000 | ||||
Ending balance at Dec. 31, 2021 | $ 838,848 | $ 190 | 688,290 | (4,013) | 154,381 |
Beginning balance (in shares) at Sep. 30, 2021 | 0 | ||||
Beginning balance at Sep. 30, 2021 | $ 0 | ||||
Ending balance (in shares) at Dec. 31, 2021 | 0 | ||||
Ending balance at Dec. 31, 2021 | $ 0 | ||||
Beginning balance (in shares) at Sep. 30, 2021 | 186,971,000 | ||||
Beginning balance at Sep. 30, 2021 | 772,560 | $ 187 | 674,414 | (775) | 98,734 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Stock-based compensation | 8,765 | 8,765 | |||
Exercise of stock options (in shares) | 3,090,000 | ||||
Exercise of stock options | 4,249 | $ 3 | 4,246 | ||
Vesting of restricted stock units (in shares) | 10,000 | ||||
Tax withholding on shares under stock-based compensation awards | (380) | (380) | |||
Common stock warrant expense | 1,245 | 1,245 | |||
Other comprehensive income (loss) | (3,238) | (3,238) | |||
Net income | 55,647 | 55,647 | |||
Ending balance (in shares) at Dec. 31, 2021 | 190,071,000 | ||||
Ending balance at Dec. 31, 2021 | $ 838,848 | $ 190 | 688,290 | (4,013) | 154,381 |
Beginning balance (in shares) at Mar. 31, 2022 | 0 | ||||
Beginning balance at Mar. 31, 2022 | $ 0 | ||||
Ending balance (in shares) at Sep. 30, 2022 | 0 | ||||
Ending balance at Sep. 30, 2022 | $ 0 | ||||
Beginning balance (in shares) at Mar. 31, 2022 | 192,398,000 | ||||
Beginning balance at Mar. 31, 2022 | $ 878,594 | $ 192 | 702,589 | (15,294) | 191,107 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Repurchase and retirement of common stock (in shares) | (2,150,982) | ||||
Repurchase and retirement of common stock | $ (70,000) | ||||
Ending balance (in shares) at Sep. 30, 2022 | 192,302,000 | ||||
Ending balance at Sep. 30, 2022 | $ 878,964 | $ 192 | 730,582 | (21,559) | 169,749 |
Beginning balance (in shares) at Mar. 31, 2022 | 0 | ||||
Beginning balance at Mar. 31, 2022 | $ 0 | ||||
Ending balance (in shares) at Dec. 31, 2022 | 0 | ||||
Ending balance at Dec. 31, 2022 | $ 0 | ||||
Beginning balance (in shares) at Mar. 31, 2022 | 192,398,000 | ||||
Beginning balance at Mar. 31, 2022 | 878,594 | $ 192 | 702,589 | (15,294) | 191,107 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Stock-based compensation | 31,433 | 31,433 | |||
Exercise of stock options and common stock warrants (in shares) | 2,784,000 | ||||
Exercise of stock options and common stock warrants | $ 7,464 | $ 3 | 7,461 | ||
Exercise of stock options (in shares) | 2,659,000 | ||||
Vesting of restricted stock units (in shares) | 147,000 | ||||
Tax withholding on shares under stock-based compensation awards | $ (2,353) | (2,353) | |||
Repurchase and retirement of common stock (in shares) | (2,151,000) | ||||
Repurchase and retirement of common stock | (70,042) | $ (2) | (70,040) | ||
Common stock warrant expense | 4,035 | 4,035 | |||
Issuance of common stock in connection with the employee stock purchase plan (in shares) | 74,000 | ||||
Issuance of common stock in connection with the employee stock purchase plan | 2,341 | 2,341 | |||
Other comprehensive income (loss) | (3,448) | (3,448) | |||
Net income | 82,150 | 82,150 | |||
Ending balance (in shares) at Dec. 31, 2022 | 193,252,000 | ||||
Ending balance at Dec. 31, 2022 | $ 930,174 | $ 193 | 745,506 | (18,742) | 203,217 |
Beginning balance (in shares) at Sep. 30, 2022 | 0 | ||||
Beginning balance at Sep. 30, 2022 | $ 0 | ||||
Ending balance (in shares) at Dec. 31, 2022 | 0 | ||||
Ending balance at Dec. 31, 2022 | $ 0 | ||||
Beginning balance (in shares) at Sep. 30, 2022 | 192,302,000 | ||||
Beginning balance at Sep. 30, 2022 | 878,964 | $ 192 | 730,582 | (21,559) | 169,749 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Stock-based compensation | 12,811 | 12,811 | |||
Exercise of stock options (in shares) | 872,000 | ||||
Exercise of stock options | 1,856 | $ 1 | 1,855 | ||
Vesting of restricted stock units (in shares) | 78,000 | ||||
Tax withholding on shares under stock-based compensation awards | (1,092) | (1,092) | |||
Common stock warrant expense | 1,350 | 1,350 | |||
Other comprehensive income (loss) | 2,817 | 2,817 | |||
Net income | 33,468 | 33,468 | |||
Ending balance (in shares) at Dec. 31, 2022 | 193,252,000 | ||||
Ending balance at Dec. 31, 2022 | $ 930,174 | $ 193 | $ 745,506 | $ (18,742) | $ 203,217 |
CONDENSED CONSOLIDATED STATEM_5
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 9 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Cash flows from operating activities | ||
Net income | $ 82,150 | $ 118,057 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 7,575 | 3,672 |
Deferred income taxes | 9,392 | (31,972) |
Stock-based compensation, net of amounts capitalized | 34,843 | 21,633 |
Non-cash lease expense | 1,490 | 857 |
Amortization of premium on marketable securities, net | 3,144 | 2,863 |
Loss on sale of marketable securities | 1,093 | 525 |
Amortization of deferred contract costs | 6,357 | 7,366 |
Other | 797 | 120 |
Changes in operating assets and liabilities, net of effect of acquisition: | ||
Accounts receivable | 6,191 | (19,579) |
Prepaid expenses and other assets | 1,924 | (7,003) |
Deferred contract costs | (6,409) | (6,672) |
Accounts payable, accrued expenses and other liabilities | 2,723 | 8,093 |
Deferred revenue | (18,098) | (17,538) |
Operating lease liabilities | (209) | (811) |
Net cash provided by operating activities | 132,963 | 79,611 |
Cash flows from investing activities | ||
Cash paid for acquisition | (53,500) | 0 |
Purchases of property and equipment | (1,680) | (852) |
Internal-use software development costs | (3,478) | (2,736) |
Purchases of marketable securities | (130,257) | (1,271,915) |
Maturities of marketable securities | 35,014 | 41,617 |
Sales of marketable securities | 107,182 | 616,938 |
Net cash used in investing activities | (46,719) | (616,948) |
Cash flows from financing activities | ||
Proceeds from issuance of common stock upon initial public offering after deducting underwriting discounts and commissions | 0 | 553,905 |
Proceeds from issuance of common stock upon exercise of stock options and common stock warrants | 7,455 | 9,234 |
Proceeds from issuance of common stock in connection with the employee stock purchase plan | 2,341 | 0 |
Taxes paid related to net share settlement of equity awards | (2,353) | (436) |
Repurchase of common stock | (70,042) | (2,698) |
Payments of deferred offering costs | 0 | (3,982) |
Net cash provided by (used in) financing activities | (62,599) | 556,023 |
Net increase in cash and cash equivalents | 23,645 | 18,686 |
Cash and cash equivalents, beginning of period | 112,809 | 66,393 |
Cash and cash equivalents, end of period | 136,454 | 85,079 |
Supplemental disclosures of cash flow information | ||
Cash paid for taxes | 2,504 | 182 |
Non-cash financing and investing activities | ||
Conversion of redeemable convertible preferred stock to common stock | 0 | 81,458 |
Capitalized stock-based compensation for internal-use software development costs | 625 | 317 |
Fair value of contingent earn-out consideration included in purchase consideration | 21,134 | 0 |
Operating lease right-of-use assets obtained in exchange for operating lease liabilities | $ 14,759 | $ 1,151 |
Description of Business
Description of Business | 9 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Description of Business | Description of Business Description of Business Doximity, Inc. (the “Company”) was incorporated in the state of Delaware in April 2010 as 3MD Communications, Inc. and is headquartered in San Francisco, California. The Company subsequently changed its name to Doximity, Inc. in June 2010. The Company provides an online platform, which enables physicians and other healthcare professionals to collaborate with their colleagues, securely coordinate patient care, stay up to date with the latest medical news and research, monitor their work schedules, and manage their careers. The Company’s customers primarily include pharmaceutical companies and health systems that connect with healthcare professionals through the Company’s digital Marketing and Hiring Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential physician candidates. Initial Public Offering In June 2021, the Company completed its initial public offering (“IPO”), in which the Company issued and sold 22,505,750 shares of its Class A common stock at $26.00 per share, including 3,495,000 shares issued upon the exercise of the underwriters’ option to purchase additional shares. The Company received proceeds of $548.5 million after deducting underwriting discounts and commissions as well as deferred offering costs. In connection with the IPO, all 76,286,618 shares of the Company’s outstanding redeemable convertible preferred stock automatically converted into an equivalent number of shares of Class B common stock on a one-to-one basis. Deferred offering costs, which consist of direct incremental legal, consulting, banking, and accounting fees relating to the Company’s planned initial public offering, were capitalized. Upon the consummation of the IPO, $5.5 million of deferred offering costs were offset against proceeds. Stock Split |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 9 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies There have been no material changes to the significant accounting policies of the Company as compared to those described in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2022 and filed with the SEC on May 27, 2022. Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2022. The accompanying condensed consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. In the opinion of the Company’s management, the information contained herein reflects all adjustments necessary for a fair presentation of the Company’s financial position, results of operations, stockholders’ equity, and cash flows. The results of operations for the three and nine months ended December 31, 2022, shown in this report are not necessarily indicative of the results to be expected for the full year ending March 31, 2023. Certain prior year amounts were reclassified, as applicable, to conform to the current year presentation. Fiscal Year The Company’s fiscal year ends on March 31 st . Unless otherwise noted, all references to a particular year shall mean the Company’s fiscal year. Use of Estimates The preparation of the Company’s condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts stated in the condensed consolidated financial statements and accompanying notes. These judgments, estimates, and assumptions are used for, but not limited to, revenue recognition, the fair values of acquired intangible assets and goodwill, the useful lives of long-lived assets, the valuation of the Company’s common stock and stock-based awards, fair value of contingent earn-out consideration, and deferred income taxes. The Company bases its estimates on historical experience and on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates due to risks and uncertainties, including uncertainty in the current economic environment. Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. The primary focus of the Company’s investment strategy is to preserve capital and meet liquidity requirements. The Company’s investment policy addresses the level of credit exposure by limiting the concentration in any one corporate issuer or sector and establishing a minimum allowable credit rating. To manage risk exposure, the Company invests cash equivalents and marketable securities in a variety of fixed income securities, including government and investment-grade debt securities and money market funds. The Company places its cash primarily in checking and money market accounts with reputable financial institutions. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits, if any. Concentrations of credit risk with respect to accounts receivable are primarily limited to certain customers to which the Company makes substantial sales. The Company’s significant customers that represented 10% or more of revenue or accounts receivable, net for the periods presented were as follows: Revenue Accounts Receivable, Net Three Months Ended December 31, Nine Months Ended December 31, December 31, 2022 March 31, 2022 2022 2021 2022 2021 Customer A * * * 10 % * 21 % Customer B * * * * 10 % * _______________ * Less than 10% For the purpose of assessing the concentration of credit risk for significant customers, the Company defines a customer as an entity that purchases the Company’s services directly or indirectly through marketing agencies. Accounting Pronouncements Recently Adopted In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , that simplifies the accounting for income taxes by removing certain exceptions to the general principles in such areas as intraperiod tax allocation, year-to-date losses in interim periods, and deferred tax liabilities related to outside basis differences. Amendments also include simplifications in other areas such as franchise taxes, step-up in tax basis goodwill, separate entity financial statements, and interim recognition of enactment of tax laws or rate changes. Most amendments within this guidance are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company adopted this guidance on April 1, 2022, and the adoption of this guidance did not have a material impact on the condensed consolidated financial statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customer , which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Topic 606, Revenue from Contracts with Customers, |
Revenue Recognition
Revenue Recognition | 9 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenue Recognition | Revenue Recognition The Company’s revenue is primarily derived from the sale of subscriptions for the following solutions: • Marketing Solutions : Hosting of customer-sponsored content on the Doximity platform and providing access to the Company’s professional database of healthcare professionals for referral or marketing purposes during the subscription period. • Hiring Solutions : Providing customers access to the Company’s professional tools where recruiters can access the Company’s database of healthcare professionals, allowing customers to send messages for talent sourcing and to share job postings during the subscription period. The Company determines revenue recognition in accordance with ASC 606, Revenue from Contracts with Customers , through the following five steps: 1) Identify the contract with a customer The Company considers the terms and conditions of its contracts and the Company’s customary business practices in identifying its contracts under ASC 606. The Company determines it has a contract with a customer when the contract has been approved by both parties, it can identify each party’s rights regarding the services to be transferred and the payment terms for the services, it has determined that the customer has the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract. The Company applies judgment in determining the customer’s ability and intent to pay, which is based on a variety of factors, including the customer’s payment history or, in the case of a new customer, the customer’s credit and financial information. Contractual terms for Marketing Solutions contracts are generally 12 months or less. The contractual term for Hiring Solutions contracts is typically 12 months. Customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones. Certain Marketing Solutions contracts are cancellable with a 30-day notice period. The Company is not required to refund any prepayment fees invoiced and customers are responsible for prorated amounts to cover services that were provided but payment was not made. Hiring Solutions contracts are noncancellable and customers are billed in annual, quarterly, or monthly installments in advance of the service period. 2) Identify the performance obligations in the contract Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. Marketing Solutions customers may purchase a subscription for a specific module to be used over a defined period of time. These customers may purchase more than one module with either the same or different subscription periods. Modules are the core building blocks of the customers’ marketing plan and can be broadly categorized as Awareness, Interactivity, and Peer. As an example, the Company’s Awareness modules may include: • A sponsored article, including a headline that appears in the targeted member’s newsfeed. • Short, animated videos that are presented in targeted members’ newsfeeds. • Short-form content that is presented within the targeted members’ newsfeeds. Each module targets a consistent number of Doximity members per month for the duration of the subscription period. The Company treats each subscription to a specific module as a distinct performance obligation because each module is capable of being distinct as the customer can benefit from the subscription to each module on their own and each subscription can be sold standalone. Furthermore, the subscriptions to individual modules are distinct in the context of the contract as (1) the Company is not integrating the services with other services promised in the contract into a bundle of services that represent a combined output, (2) the subscriptions to specific modules do not significantly modify or customize the subscription to another module, and (3) the specific modules are not highly interdependent or highly interrelated. The subscription to each module is treated as a series of distinct performance obligations because it is distinct and substantially the same, satisfied over time, and has the same measure of progress. Marketing Solutions customers may also purchase integrated subscriptions for a fixed subscription fee that are not tied to a single module but allow customers to utilize any combination of modules during the subscription period, subject to limits on the total number of modules launched in a given period of time, active at any given time, and members targeted. These represent stand-ready obligations in that the delivery of the underlying sponsored content is within the control of the customer and the extent of use in any given period does not diminish the remaining services. Subscriptions to Hiring Solutions provide customers access to the platform to place targeted job postings and send a fixed number of monthly messages. Each subscription is treated as a series of distinct performance obligations that are satisfied over time. 3) Determine the transaction price The transaction price is determined based on the consideration the Company expects to be entitled to in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue recognized under the contract will not occur. The Company may generate sales through the use of third-party media agencies that are authorized to enter into contracts on behalf of an end customer. The Company acts as the principal in these transactions since it maintains control prior to transferring the service to the customer and is primarily responsible for the fulfillment that occurs through the Company’s platform. The Company records revenue for the amount to which it is entitled from the third-party media agencies as the Company does not know and expects not to know the price charged by the third-party media agencies to its customers. Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental entities. 4) Allocate the transaction price to performance obligations in the contract If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative stand-alone selling price (“SSP”). The determination of a SSP for each distinct performance obligation requires judgment. The Company determines SSP for performance obligations based on overall pricing objectives, which take into consideration market conditions and customer-specific factors, including a review of internal discounting tables, the type of services being sold, and other factors. The estimate of SSP is based on historical sales of standalone services. The Company estimates the SSP for arrangements where standalone sales do not provide sufficient evidence of the SSP. The Company believes the use of its estimation approach and allocation of the transaction price on a relative SSP basis to each performance obligation results in revenue recognition in a manner consistent with the underlying economics of the transaction and the allocation principle included in ASC 606. 5) Recognize revenue when or as the Company satisfies a performance obligation Revenue is recognized when or as control of the promised goods or service is transferred to the customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. Subscriptions represent a series of distinct goods or services because the performance obligations are satisfied over time as customers simultaneously receive and consume the benefits related to the services as the Company performs. In the case of module specific subscriptions, a consistent level of service is provided during each monthly period the sponsored content is available on the Company’s platform. The Company commences revenue recognition when the first content is launched on the platform for the initial monthly period and revenue is recognized over time as each subsequent content period is delivered. The Company’s obligation for its integrated subscriptions is to stand-ready throughout the subscription period; therefore, the Company considers an output method of time to measure progress towards satisfaction of its obligations, with revenue commencing upon the beginning of the subscription period. The Company treats Hiring Solutions subscriptions as a single performance obligation that represents a series of distinct performance obligations that is satisfied over time. Revenue recognition commences when the customer receives access to the services. Revenue Disaggregation Revenue consisted of the following (in thousands): Three Months Ended December 31, Nine Months Ended December 31, 2022 2021 2022 2021 Subscription $ 107,508 $ 91,066 $ 286,556 $ 233,510 Other 7,754 6,810 21,530 16,385 Total revenue $ 115,262 $ 97,876 $ 308,086 $ 249,895 Other revenue consists of fees earned from the temporary staffing and permanent placement of healthcare professionals. Contract Balances Timing of revenue recognition may differ from the timing of invoicing to customers. A majority of customers are invoiced throughout the contract, while others are billed upfront. Marketing Solutions customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones, starting when the tailored content is first shared on the Doximity platform. The Company’s contracts do not contain significant financing components. The Company records unbilled revenue when revenue is recognized in amounts for which it is contractually entitled but exceeds the amounts the Company has a right to bill as of the end of the period. The Company records unbilled revenue on the condensed consolidated balance sheets within prepaid expenses and other current assets. The Company’s unbilled revenue balances were $2.8 million and $1.4 million as of December 31, 2022 and March 31, 2022, respectively. Deferred revenue consists of noncancelable customer billings or payments received in advance of revenue recognition. Deferred revenue balances are generally expected to be recognized within 12 months. Since the majority of the Company’s contracts have a duration of one year or less, the Company has elected not to disclose remaining performance obligations in accordance with the optional exemption in ASC 606. Remaining performance obligations for contracts with an original duration greater than one year are not material. Revenue recognized for the three months ended December 31, 2022 and 2021 from amounts included in deferred revenue as of the beginning of the period was $65.6 million and $58.0 million, respectively. Revenue recognized for the nine months ended December 31, 2022 and 2021 from amounts included in deferred revenue as of the beginning of the period was $81.8 million and $79.6 million, respectively. Deferred Contract Costs The Company capitalizes sales compensation that is considered to be incremental and recoverable costs of obtaining a contract with a customer. Sales compensation earned for the renewal of Marketing Solutions contracts is commensurate with compensation earned for a new or expansion Marketing Solutions contract, whereas compensation for the renewal of Hiring Solutions subscription contracts is earned at a lower rate than for new and expansion Hiring Solutions subscription contracts. Deferred compensation for Marketing Solutions contracts and Hiring Solutions renewal contracts is amortized over the weighted-average contractual term, ranging from 7 months to 13 months. Deferred compensation tied to new and expansion contracts for Hiring Solutions is amortized on a straight-line basis over the expected period of benefit of 4 years, which is determined by the nature of the Company’s technology and services, the rate at which the Company continually enhances and updates its technology, and its historical customer retention. The portion of deferred compensation expected to be recognized within one year of the balance sheet date is recorded as deferred contract costs, current, and the remaining portion is recorded as other assets on the condensed consolidated balance sheets. Amortized costs are included in cost of revenue and sales and marketing expense in the condensed consolidated statements of operations. Sales compensation that are not considered incremental costs are expensed in the same period as they are earned. The Company capitalized $4.1 million and $6.4 million of contract acquisition costs for the three and nine months ended December 31, 2022, respectively, and $3.7 million and $6.7 million of contract acquisition costs for the three and nine months ended December 31, 2021, respectively. Amortization of deferred contract costs was $1.5 million and $6.4 million for the three and nine months ended December 31, 2022, respectively, and $1.7 million and $7.4 million for the three and nine months ended December 31, 2021, respectively. |
Investments
Investments | 9 Months Ended |
Dec. 31, 2022 | |
Investments, Debt and Equity Securities [Abstract] | |
Investments | Investments The cost, gross unrealized gains and losses, and fair value of investments are as follows (in thousands): As of December 31, 2022 Cost or Gross Gross Fair Value Cash equivalents: Commercial paper $ 16,459 $ — $ (4) $ 16,455 Money market funds 6,580 — — 6,580 Total cash equivalents 23,039 — (4) 23,035 Marketable securities: Asset-backed securities 7,754 — (119) 7,635 Certificates of deposit 15,414 — (111) 15,303 Commercial paper 52,531 5 (112) 52,424 Corporate notes and bonds 144,640 5 (1,515) 143,130 Sovereign bonds 7,743 — (463) 7,280 U.S. government and agency securities 461,540 — (22,801) 438,739 Total marketable securities 689,622 10 (25,121) 664,511 Total cash equivalents and marketable securities $ 712,661 $ 10 $ (25,125) $ 687,546 As of December 31, 2022, the contractual maturities of the Company’s available-for-sale debt securities were as follows (in thousands): Fair Value Due within one year $ 309,888 Due in one year to three years 371,078 Total $ 680,966 The cost, gross unrealized gains and losses, and fair value of investments were as follows (in thousands): As of March 31, 2022 Cost or Gross Gross Fair Value Cash equivalents: Commercial paper $ 2,686 $ — $ — $ 2,686 Money market funds 20,072 — — 20,072 Total cash equivalents 22,758 — — 22,758 Marketable securities: Asset-backed securities 7,791 — (51) 7,740 Commercial paper 9,436 — (53) 9,383 Corporate notes and bonds 129,900 — (1,796) 128,104 Sovereign bonds 8,770 — (334) 8,436 U.S. government and agency securities 549,901 — (18,260) 531,641 Total marketable securities 705,798 — (20,494) 685,304 Total cash equivalents and marketable securities $ 728,556 $ — $ (20,494) $ 708,062 As of December 31, 2022 and March 31, 2022, the Company has recognized accrued interest of $2.2 million and $2.1 million, respectively, which is included in prepaid expenses and other current assets in the condensed consolidated balance sheets. The unrealized losses associated with the Company’s debt securities were $25.1 million as of December 31, 2022. As the Company does not intend to sell these securities and it is more likely than not that the Company will hold these securities until maturity or until the cost basis is recovered, the Company did not recognize any impairment on these securities as of December 31, 2022. The Company did not recognize any credit losses related to the Company’s debt securities during the three and nine months ended December 31, 2022. The fair value related to the debt securities with unrealized losses for which no credit losses were recognized was $649.5 million as of December 31, 2022. The unrealized losses associated with the Company’s debt securities were $5.4 million as of December 31, 2021. The Company did not recognize any credit losses or impairment related to the Company’s debt securities during the three and nine months ended December 31, 2021. The fair value related to the debt securities with unrealized losses for which no credit losses were recognized was $678.8 million as of December 31, 2021. |
Fair Value Measurements
Fair Value Measurements | 9 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements Available-for-sale debt securities are recorded at fair value on the condensed consolidated balance sheets. The carrying value of cash equivalents, accounts receivable, accounts payable, and accrued expenses and other current liabilities approximate their respective fair values due to their short maturities. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1 —Inputs that are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date. Level 2 —Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life. Level 3 —Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities and which reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. The following tables present the fair value hierarchy for the Company’s assets and liabilities measured at fair value on a recurring basis (in thousands): As of December 31, 2022 Level 1 Level 2 Level 3 Total Cash equivalents: Commercial paper $ — $ 16,455 $ — $ 16,455 Money market funds 6,580 — — 6,580 Total cash equivalents 6,580 16,455 — 23,035 Marketable securities: Asset-backed securities — 7,635 — 7,635 Certificates of deposit — 15,303 — 15,303 Commercial paper — 52,424 — 52,424 Corporate notes and bonds — 143,130 — 143,130 Sovereign bonds — 7,280 — 7,280 U.S. government and agency securities 438,739 — — 438,739 Total marketable securities 438,739 225,772 — 664,511 Total cash equivalents and marketable securities $ 445,319 $ 242,227 $ — $ 687,546 Liabilities: Contingent earn-out consideration liability $ — $ — $ 21,457 $ 21,457 Total contingent earn-out consideration liability $ — $ — $ 21,457 $ 21,457 As of March 31, 2022 Level 1 Level 2 Level 3 Total Cash equivalents: Commercial paper $ — $ 2,686 $ — $ 2,686 Money market funds 20,072 — — 20,072 Total cash equivalents 20,072 2,686 — 22,758 Marketable securities: Asset-backed securities — 7,740 — 7,740 Commercial paper — 9,383 — 9,383 Corporate notes and bonds — 128,104 — 128,104 Sovereign bonds — 8,436 — 8,436 U.S. government and agency securities 530,174 1,467 — 531,641 Total marketable securities 530,174 155,130 — 685,304 Total cash equivalents and marketable securities $ 550,246 $ 157,816 $ — $ 708,062 During the nine months ended December 31, 2022 and 2021, the Company had no transfers between levels of the fair value hierarchy. Contingent Earn-out Consideration Liability The following table summarizes the changes in the contingent earn-out consideration liability (in thousands): Nine Months Ended December 31, 2022 Beginning fair value $ — Additions in the period 21,134 Change in fair value 323 Ending fair value $ 21,457 The contingent earn-out consideration liability relates to the AMiON acquisition, which closed on April 1, 2022. The fair value of the liability is remeasured at each reporting date until the related contingency is resolved, with any changes to the fair value recognized as sales and marketing expense in the condensed consolidated statements of operations. To determine the fair value of the contingent earn-out consideration liability, the Company used the discounted cash flow method. The significant inputs used in the fair value measurement of the contingent earn-out consideration liability are the discount rate and the timing and amounts of the future payments, which are based upon estimates of future achievement of the performance metrics. As these inputs are not based on observable market data, they represent a Level 3 measurement within the fair value hierarchy. Changes in the significant inputs used would significantly impact the fair value of the contingent earn-out consideration liability. |
Property and Equipment, Net
Property and Equipment, Net | 9 Months Ended |
Dec. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment, Net | Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): December 31, 2022 March 31, 2022 Furniture and equipment $ 2,795 $ 336 Computers and software 745 769 Leasehold improvements 889 796 Internal-use software development costs 19,160 15,057 Total property and equipment 23,589 16,958 Less: accumulated depreciation and amortization (12,070) (8,470) Total property and equipment, net $ 11,519 $ 8,488 Depreciation and amortization expense on property and equipment for the three and nine months ended December 31, 2022 was $1.4 million and $4.0 million, respectively. Included in these amounts was amortization expense for internal-use software development costs of $1.2 million and $3.5 million for the three and nine months ended December 31, 2022, respectively. Depreciation and amortization expense on property and equipment for the three and nine months ended December 31, 2021 was $1.1 million and $2.8 million, respectively. Included in these amounts was amortization expense for internal-use software development costs of $1.0 million and $2.5 million for the three and nine months ended December 31, 2021, respectively. The amortization of the internal-use software development costs is included in cost of revenue in the condensed consolidated statements of operations. During the three and nine months ended December 31, 2022, the Company capitalized $1.2 million and $4.1 million, respectively, and, during the three and nine months ended December 31, 2021, capitalized $1.2 million and $3.1 million, respectively, of internal-use software development costs, which are included in property and equipment, net in the condensed consolidated balance sheets. No impairment was recognized on property and equipment during the three and nine months ended December 31, 2022 and 2021. |
Accrued Expenses and Other Curr
Accrued Expenses and Other Current Liabilities | 9 Months Ended |
Dec. 31, 2022 | |
Payables and Accruals [Abstract] | |
Accrued Expenses and Other Current Liabilities | Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): December 31, 2022 March 31, 2022 Accrued commissions $ 8,352 $ 6,653 Accrued payroll, bonus, and related expenses 8,435 8,015 Employee contributions under employee stock purchase plan 1,861 621 Rebate liabilities 2,328 4,933 Sales and other tax liabilities 1,568 785 Current portion of contingent earn-out consideration liability 5,832 — Other 4,775 4,263 Total accrued expenses and other current liabilities $ 33,151 $ 25,270 |
Business Combinations
Business Combinations | 9 Months Ended |
Dec. 31, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Business Combinations | Business Combinations AMiON Acquisition On April 1, 2022, the Company completed the acquisition of the assets of the AMiON on-call scheduling and messaging application used by scheduling staff and physicians (“the AMiON acquisition”) to further expand our physician cloud platform. The acquisition-date fair value of the consideration was $74.6 million, consisting of $53.5 million in cash and $21.1 million in fair value of contingent earn-out consideration. Under the definitive agreement for the AMiON acquisition, the Company will pay contingent earn-out consideration of up to $24.0 million, of which $4.0 million is a minimum guarantee and the remaining $20.0 million is subject to the achievement of certain operational performance metrics over the next four years. The contingent earn-out consideration is payable in cash in annual installments over the next four years. The contingent earn-out consideration is classified as a liability, the short-term portion of which is included in accrued expenses and other current liabilities and the long-term portion is in contingent earn-out consideration liability, non-current in the condensed consolidated balance sheets. See Note 5—Fair Value Measurements for additional information regarding the valuation of the contingent earn-out consideration liability. Additionally, in May 2022, 93,458 restricted stock units (“RSUs”) with a grant date fair value of $32.99 per share were granted to the eligible employees joining the Company in connection with the AMiON acquisition. The shares will vest on a quarterly basis over four years based on continued service. The aggregate grant date fair value of these RSUs will be accounted for as post-acquisition stock-based compensation expense and will be recognized on a straight-line basis over the requisite service period. The AMiON acquisition was accounted for as a business combination. The purchase consideration was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess recorded to goodwill as shown below. The purchase consideration allocation was as follows (in thousands): Assets acquired: Accounts receivable $ 447 Customer relationships 27,200 Software technology 820 Trademark 700 Total assets acquired $ 29,167 Liabilities assumed: Deferred revenue $ 2,925 Other liabilities 633 Net assets acquired, excluding goodwill 25,609 Goodwill $ 49,025 Total purchase consideration $ 74,634 Goodwill generated from the AMiON acquisition represents the future benefits from the development of future customer relationships and the assembled workforce. Goodwill from this business combination is deductible for income tax purposes. Intangible assets acquired are comprised of customer relationships, trademarks, and software technology with estimated useful lives of 9 years, 3 years, and 18 months, respectively. The fair value assigned to the customer relationships was determined primarily using the multiple period excess earnings method cost approach, which estimates the direct cash flows expected to be generated from the existing customers acquired. The results of operations of this business combination have been included in the condensed consolidated financial statements from the acquisition date. The acquisition-related costs were not material and were recorded as general and administrative expense in the condensed consolidated statements of operations. |
Intangible Assets and Goodwill
Intangible Assets and Goodwill | 9 Months Ended |
Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets and Goodwill | Intangible Assets and Goodwill Intangible Assets Intangible assets, net consisted of the following (in thousands): December 31, 2022 March 31, 2022 Customer relationships $ 37,069 $ 9,869 Other intangibles 1,531 11 Total intangible assets 38,600 9,880 Less: accumulated amortization (5,566) (1,971) Total intangible assets, net $ 33,034 $ 7,909 Amortization expense for intangible assets was $1.2 million and $3.6 million for the three and nine months ended December 31, 2022, respectively. Amortization expense for intangible assets was $0.3 million and $0.9 million for the three and nine months ended December 31, 2021, respectively. No impairment charges on intangible assets were recorded during the three and nine months ended December 31, 2022 and 2021. As of December 31, 2022, future amortization expense is as follows (in thousands): Year Ending March 31, Amount Remainder of 2023 $ 1,198 2024 4,519 2025 4,245 2026 4,012 2027 4,010 2028 4,010 Thereafter 11,040 Total future amortization expense $ 33,034 Goodwill The changes in the carrying amount of goodwill were as follows (in thousands): Nine Months Ended December 31, 2022 Balance, beginning of period $ 18,915 Goodwill acquired 49,025 Balance, end of period $ 67,940 |
Equity
Equity | 9 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Equity | Equity Preferred Stock In connection with the IPO, the Company’s amended and restated certificate of incorporation became effective, which authorized the issuance of 100,000,000 shares of undesignated preferred stock with a par value of $0.001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors. As of December 31, 2022 and March 31, 2022, there were no shares of preferred stock issued and outstanding. Common Stock and Creation of Dual-Class Structure The Company has two classes of common stock authorized: Class A common stock and Class B common stock, and are collectively referred to as common stock throughout the notes to the condensed consolidated financial statements, unless otherwise noted. On June 8, 2021, the Company’s board of directors and stockholders approved an amendment to the Company’s amended and restated certificate of incorporation which authorized 1,000,000,000 shares of Class A common stock with par value of $0.001 and one vote per share, and 500,000,000 shares of Class B common stock with par value of $0.001 and ten votes per share. The holders of common stock are entitled to receive dividends, as may be declared by the board of directors. Each of the Company’s 85,523,836 shares of then-existing common stock outstanding was reclassified into Class B common stock. Each outstanding share of Class B common stock may be converted at any time at the option of the holder into one share of Class A common stock. As of December 31, 2022, there were 118,355,360 shares of Class A common stock, and 74,896,344 shares of Class B common stock outstanding. Stock Repurchase Program On May 12, 2022, the Company’s board of directors authorized a program to repurchase up to $70 million of the Company’s Class A common stock. As of September 30, 2022, the Company repurchased and retired 2,150,982 shares of Class A common stock for an aggregate purchase price of $70.0 million, thereby completing this share repurchase program. On October 28, 2022, the Company’s board of directors authorized an additional program to repurchase up to $70 million of the Company’s Class A common stock. The repurchases may be executed from time to time over the next 12 months, subject to general business and market conditions and other investment opportunities, through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans. Immediately upon the repurchase of any shares of Class A common stock, such shares shall be retired by the Company and shall automatically return to the status of authorized but unissued shares of Class A common stock. The Company did not repurchase any shares of common stock under this share repurchase program during the quarter ended December 31, 2022. Common Stock Warrants In March 2017, the Company issued a warrant to purchase 250,000 shares of common stock at an exercise price of $0.72 per share in connection with a contract signed between the Company and U.S. News & World Report, L.P., or U.S. News. The warrant expires 10 years from the date of grant. As of December 31, 2022, the warrant was fully vested. During the nine months ended December 31, 2022, the warrant for 125,000 shares were exercised with an intrinsic value of $4.0 million. The remaining warrant for 125,000 shares was outstanding as of December 31, 2022. In October 2021, the Company issued a warrant to U.S. News (the “U.S. News Warrant”) to purchase 516,000 shares of Class A common stock with an exercise price of $12.56 per share in connection with the execution of a commercial agreement with the U.S. News (the “Commercial Agreement”). The U.S. News Warrant expires 10 years from the date of grant. The first tranche of the U.S. News Warrant vested on May 1, 2022 and the remainder will vest on a monthly basis over approximately 6 years. The grant-date fair value of the U.S. News Warrant was $34.7 million, which was determined using the Black-Scholes option-pricing model on the date of grant using the following assumptions: fair value of common stock of $76.50, volatility of 46.9%, risk-free interest rate of 1.61%, contractual term of 10 years, and an expected dividend of 0%. The fair value of the warrant is recognized as expense in cost of revenue in the condensed consolidated statements of operations on a straight-line basis over its vesting term of 6.48 years. During the nine months ended December 31, 2022, $4.0 million was recognized as stock-based compensation expense relating to the U.S. News Warrant. As of December 31, 2022, unamortized compensation expense, net of estimated forfeitures, related to the unvested warrants was $28.1 million, which is expected to be recognized over the remaining vesting period of 5.25 years. Equity Incentive Plans The Company maintains three equity incentive plans: the 2010 Equity Incentive Plan (the “2010 Plan”), the 2021 Stock Option and Incentive Plan (the “2021 Plan”), and the 2021 Employee Stock Purchase Plan (the “ESPP”). Upon IPO, the 2021 Plan became effective and the 2010 Plan was terminated. The 2010 Plan continues to govern the terms of outstanding awards that were granted prior to the termination of the 2010 Plan. The 2021 Plan provides for the granting of incentive stock options, nonstatutory stock options, restricted stock units, and restricted stock awards to employees, non-employee directors, and consultants of the Company. On May 27, 2022, the Company filed a Registration Statement on Form S-8 which registered an additional 9,619,921 shares of Class A common stock issuable under the 2021 Plan and 1,923,984 shares of its Class A common stock issuable under the ESPP. The Company grants stock options under the terms of the Plans and outside of the Plans, as approved by the board of directors. During fiscal 2018, the Company granted 4,682,582 options outside of the Plans, of which 2,027,917 options were exercised and 2,654,665 were outstanding as of December 31, 2022. The Company has shares of common stock reserved for issuance as follows (in thousands): December 31, 2022 Common stock warrants 641 2010 Plan Options outstanding 21,223 2021 Plan Awards outstanding 2,022 Shares available for future grant 30,945 2021 ESPP 6,321 Options outstanding outside the plans 2,655 Total 63,807 Stock Options Stock options granted generally vest over four years with service-based, performance-based, and/or market-based conditions and expire ten years from the date of grant. Stock option activities within the Plans as well as outside of the Plans were as follows: Number of Shares Weighted-Average Average Remaining Contractual Term Aggregate Intrinsic Value (in thousands) Balance, March 31, 2022 26,983 $ 4.15 7.63 $ 1,293,545 Options exercised (2,659) 2.77 Options forfeited or expired (446) 5.62 Balance, December 31, 2022 23,878 4.27 6.95 699,367 Vested and exercisable as of December 31, 2022 11,697 2.35 5.97 365,043 Vested and expected to vest as of December 31, 2022 22,476 4.19 6.89 660,023 The aggregate intrinsic value of options exercised during the nine months ended December 31, 2022 and 2021 was $85.3 million and $406.9 million, respectively. As of December 31, 2022, unamortized compensation expense, net of estimated forfeitures, related to unvested stock options was $41.2 million, which is expected to be recognized over a weighted-average period of 2.97 years. The weighted-average grant-date fair value of options granted for the nine months ended December 31, 2021 was $10.73. The Company has not granted any stock options since the first quarter of fiscal 2022. The fair value of each option on the date of grant was determined using the Black-Scholes option-pricing model with the assumptions set forth in the following table: Nine Months Ended December 31, 2021 Fair value of common stock $18.41 - $21.41 Volatility 46.5% - 47.0% Risk-free interest rate 0.77% - 1.02% Expected term (in years) 5.00 - 6.09 Expected dividend —% Restricted Stock Units ("RSUs") RSUs granted by the Company are valued using the closing stock price of the company’s Class A common stock, which is traded on the NYSE, on the day of grant and will generally vest over four years based on continued service. The following table summarizes RSU activity (in thousands, except per share information): Number of Shares Weighted- Unvested balance, March 31, 2022 534 $ 68.23 Granted 1,590 33.91 Vested (203) 54.44 Forfeited (92) 46.55 Unvested balance, December 31, 2022 1,829 41.01 The total fair value of RSUs vested during the nine months ended December 31, 2022 and 2021 was $7.0 million and $1.4 million, respectively. As of December 31, 2022, total unrecognized stock-based compensation cost, net of estimated forfeitures, related to unvested RSUs was $57.0 million, and is expected to be recognized over a weighted-average period of approximately 3.25 years. Performance-Based Restricted Stock Units ("PSUs") As of December 31, 2022, the Company had 193,455 PSUs outstanding, of which 73,377 were probable of vesting. The PSUs have performance-based vesting conditions that are satisfied upon meeting certain financial performance targets. The PSUs are valued using the closing stock price of the Company’s Class A common stock, which is traded on the NYSE, on the day of grant. As of December 31, 2022, the remaining unrecognized compensation expense relating to the PSUs probable of vesting, net of estimated forfeitures, was $1.7 million. Stock-Based Compensation Expense Total stock-based compensation expense recognized in the condensed consolidated statements of operations was as follows (in thousands): Three Months Ended December 31, Nine Months Ended December 31, 2022 2021 2022 2021 Cost of revenue $ 2,695 $ 1,912 $ 7,209 $ 2,973 Research and development 4,002 2,035 9,416 4,864 Sales and marketing 4,856 2,681 11,912 5,575 General and administrative 2,431 3,206 6,306 8,221 Total stock-based compensation expense $ 13,984 $ 9,834 $ 34,843 $ 21,633 |
Net Income Per Share Attributab
Net Income Per Share Attributable to Common Stockholders | 9 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Net Income Per Share Attributable to Common Stockholders | Net Income Per Share Attributable to Common Stockholders The following table presents the reconciliation of the numerator and denominator for calculating basic and diluted net income per share (in thousands, except per share data): Three Months Ended December 31, Nine Months Ended December 31, 2022 2021 2022 2021 Numerator Net income $ 33,468 $ 55,647 $ 82,150 $ 118,057 Less: undistributed earnings attributable to participating securities — — — (21,866) Net income attributable to Class A and Class B common stockholders, basic and diluted $ 33,468 $ 55,647 $ 82,150 $ 96,191 Denominator Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic 192,805 188,372 192,963 154,289 Dilutive effect of stock options 19,118 27,762 20,491 28,377 Dilutive effect of common stock warrants 122 247 144 230 Dilutive effect of other share-based awards 20 15 58 9 Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted 212,065 216,396 213,656 182,905 Net income per share attributable to Class A and Class B common stockholders: Basic $ 0.17 $ 0.30 $ 0.43 $ 0.62 Diluted $ 0.16 $ 0.26 $ 0.38 $ 0.53 Certain potentially dilutive securities have been excluded from the calculation of diluted net income per share during the applicable periods because their inclusion would have been anti-dilutive (in thousands): Three Months Ended December 31, Nine Months Ended December 31, 2022 2021 2022 2021 Other share-based awards 1,291 254 491 118 Common stock warrants 516 477 516 159 Total 1,807 731 1,007 277 |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Minimum Guarantees On October 8, 2021, the Company signed an amended agreement to revise and extend the existing partnership with the U.S. News for six years. This agreement can be terminated after three years by either party. Under this amended agreement, the Company pays the U.S. News a portion of the revenue generated with the end customers, subject to an annual minimum guarantee. As of December 31, 2022, the remaining annual minimum guarantee ranged from $3.0 million to $6.2 million. The total minimum guarantee for the remaining noncancelable period of 2 years was $6.6 million. Other Contractual Commitments The Company has a web hosting arrangement for 3 years ending December 31, 2024, with an annual commitment of $5.2 million. As of December 31, 2022, the total remaining commitment was $10.4 million. Indemnification The Company enters into indemnification provisions under agreements with other companies in the ordinary course of business, including, but not limited to, clients, business partners, landlords, and other parties involved in the performance of the Company’s services. Pursuant to these arrangements, the Company has agreed to indemnify, hold harmless, and reimburse the indemnified party for certain losses suffered or incurred by the indemnified party as a result of the Company’s activities. The terms of these indemnification agreements are generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. The Company maintains commercial general liability insurance and product liability insurance that may offset certain of its potential liabilities under these indemnification provisions. In addition, the Company has agreed to indemnify its officers and directors and certain key employees while they are serving in good faith in their respective capacities. To date, there have been no claims under these indemnification provisions. Legal Matters |
Leases
Leases | 9 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Leases | Leases The Company has non-cancelable operating leases for the rental of office space with various expiration dates through 2030. During the first quarter of fiscal 2023, a portion of the office space lease in Irving, Texas with an approximately 8-year term commenced and the related right-of-use asset and lease liability of $10.9 million was recognized. In the second quarter of fiscal 2023, the remaining portion of the office space lease in Irving, Texas commenced and has an 8-year term. Upon commencement, a right-of-use asset and lease liability of $3.9 million was recognized. The components of lease expense were as follows (in thousands): Three Months Ended December 31, Nine Months Ended December 31, 2022 2021 2022 2021 Operating lease cost $ 701 $ 285 $ 1,891 $ 846 Variable lease cost 15 25 187 74 Total lease cost $ 716 $ 310 $ 2,078 $ 920 Supplemental cash flow information related to leases was as follows (in thousands): Nine Months Ended December 31, 2022 2021 Cash paid for amounts included in measurement of lease liabilities—Operating cash flows $ 551 $ 782 Supplemental balance sheet information related to leases was as follows: December 31, 2022 March 31, 2022 Weighted-average remaining lease term (in years) 7.17 1.64 Weighted-average discount rate 4.18 % 3.95 % Maturities of operating lease liabilities as of December 31, 2022 were as follows (in thousands): Remainder of 2023 $ 167 2024 2,238 2025 2,411 2026 2,458 2027 2,497 Thereafter 8,656 Total future lease payments $ 18,427 Less: imputed interest (2,788) Present value of lease liabilities $ 15,639 |
Income Taxes
Income Taxes | 9 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The Company’s provision for (benefit from) income taxes for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any. The Company’s effective tax rate of 18.3% and 14.8% for the three and nine months ended December 31, 2022, respectively, was lower than the U.S. federal statutory rate, primarily due to stock-based compensation related tax benefits, which are subject to limitations for certain executive officers under IRC section 162(m), and federal and state research and development tax credits. The Company’s effective tax rate of (55.4)% and (37.1)% for the three and nine months ended December 31, 2021, respectively, was lower than the U.S. federal statutory rate, primarily due to stock-based compensation related tax benefits, which are subject to limitations for certain executive officers under IRC section 162(m). The Company’s effective tax rate is based on forecasted annual income before income taxes which may fluctuate through the rest of the year. |
Segment and Geographic Informat
Segment and Geographic Information | 9 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Segment and Geographic Information | Segment and Geographic Information The Company considers operating segments to be components of the Company in which separate financial information is available and is evaluated regularly by the Company’s chief operating decision maker in deciding how to allocate resources and in assessing performance. The chief operating decision maker for the Company is the Chief Executive Officer. The chief operating decision maker reviews financial information on a consolidated basis to make decisions about how to allocate resources and how to measure the Company’s performance. As such, the Company has determined that it has one operating and reportable segment. Substantially all of the Company’s long-lived assets were based in the United States as of December 31, 2022 and March 31, 2022. No country outside of the United States accounted for more than 10% of total revenue for the three and nine months ended December 31, 2022 and 2021. Substantially all of the Company’s revenue was derived in the United States for the three and nine months ended December 31, 2022 and 2021. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 9 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2022. |
Principles of Consolidation | The accompanying condensed consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. In the opinion of the Company’s management, the information contained herein reflects all adjustments necessary for a fair presentation of the Company’s financial position, results of operations, stockholders’ equity, and cash flows. The results of operations for the three and nine months ended December 31, 2022, shown in this report are not necessarily indicative of the results to be expected for the full year ending March 31, 2023. |
Reclassification | Certain prior year amounts were reclassified, as applicable, to conform to the current year presentation. |
Fiscal Year | Fiscal Year The Company’s fiscal year ends on March 31 st . Unless otherwise noted, all references to a particular year shall mean the Company’s fiscal year. |
Use of Estimates | Use of Estimates The preparation of the Company’s condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts stated in the condensed consolidated financial statements and accompanying notes. These judgments, estimates, and assumptions are used for, but not limited to, revenue recognition, the fair values of acquired intangible assets and goodwill, the useful lives of long-lived assets, the valuation of the Company’s common stock and stock-based awards, fair value of contingent earn-out consideration, and deferred income taxes. The Company bases its estimates on historical experience and on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates due to risks and uncertainties, including uncertainty in the current economic environment. |
Concentrations of Credit Risk | Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. The primary focus of the Company’s investment strategy is to preserve capital and meet liquidity requirements. The Company’s investment policy addresses the level of credit exposure by limiting the concentration in any one corporate issuer or sector and establishing a minimum allowable credit rating. To manage risk exposure, the Company invests cash equivalents and marketable securities in a variety of fixed income securities, including government and investment-grade debt securities and money market funds. The Company places its cash primarily in checking and money market accounts with reputable financial institutions. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits, if any. |
Accounting Pronouncements Recently Adopted | Accounting Pronouncements Recently Adopted In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , that simplifies the accounting for income taxes by removing certain exceptions to the general principles in such areas as intraperiod tax allocation, year-to-date losses in interim periods, and deferred tax liabilities related to outside basis differences. Amendments also include simplifications in other areas such as franchise taxes, step-up in tax basis goodwill, separate entity financial statements, and interim recognition of enactment of tax laws or rate changes. Most amendments within this guidance are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company adopted this guidance on April 1, 2022, and the adoption of this guidance did not have a material impact on the condensed consolidated financial statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customer , which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Topic 606, Revenue from Contracts with Customers, |
Fair Value Measurements | Fair Value Measurements Available-for-sale debt securities are recorded at fair value on the condensed consolidated balance sheets. The carrying value of cash equivalents, accounts receivable, accounts payable, and accrued expenses and other current liabilities approximate their respective fair values due to their short maturities. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1 —Inputs that are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date. Level 2 —Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life. Level 3 —Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities and which reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net | The Company’s significant customers that represented 10% or more of revenue or accounts receivable, net for the periods presented were as follows: Revenue Accounts Receivable, Net Three Months Ended December 31, Nine Months Ended December 31, December 31, 2022 March 31, 2022 2022 2021 2022 2021 Customer A * * * 10 % * 21 % Customer B * * * * 10 % * _______________ * Less than 10% |
Revenue Recognition (Tables)
Revenue Recognition (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | Revenue consisted of the following (in thousands): Three Months Ended December 31, Nine Months Ended December 31, 2022 2021 2022 2021 Subscription $ 107,508 $ 91,066 $ 286,556 $ 233,510 Other 7,754 6,810 21,530 16,385 Total revenue $ 115,262 $ 97,876 $ 308,086 $ 249,895 |
Investments (Tables)
Investments (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Investments, Debt and Equity Securities [Abstract] | |
Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments | The cost, gross unrealized gains and losses, and fair value of investments are as follows (in thousands): As of December 31, 2022 Cost or Gross Gross Fair Value Cash equivalents: Commercial paper $ 16,459 $ — $ (4) $ 16,455 Money market funds 6,580 — — 6,580 Total cash equivalents 23,039 — (4) 23,035 Marketable securities: Asset-backed securities 7,754 — (119) 7,635 Certificates of deposit 15,414 — (111) 15,303 Commercial paper 52,531 5 (112) 52,424 Corporate notes and bonds 144,640 5 (1,515) 143,130 Sovereign bonds 7,743 — (463) 7,280 U.S. government and agency securities 461,540 — (22,801) 438,739 Total marketable securities 689,622 10 (25,121) 664,511 Total cash equivalents and marketable securities $ 712,661 $ 10 $ (25,125) $ 687,546 The cost, gross unrealized gains and losses, and fair value of investments were as follows (in thousands): As of March 31, 2022 Cost or Gross Gross Fair Value Cash equivalents: Commercial paper $ 2,686 $ — $ — $ 2,686 Money market funds 20,072 — — 20,072 Total cash equivalents 22,758 — — 22,758 Marketable securities: Asset-backed securities 7,791 — (51) 7,740 Commercial paper 9,436 — (53) 9,383 Corporate notes and bonds 129,900 — (1,796) 128,104 Sovereign bonds 8,770 — (334) 8,436 U.S. government and agency securities 549,901 — (18,260) 531,641 Total marketable securities 705,798 — (20,494) 685,304 Total cash equivalents and marketable securities $ 728,556 $ — $ (20,494) $ 708,062 |
Contractual Maturities of Available-For-Sale Debt Securities | As of December 31, 2022, the contractual maturities of the Company’s available-for-sale debt securities were as follows (in thousands): Fair Value Due within one year $ 309,888 Due in one year to three years 371,078 Total $ 680,966 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value, Assets Measured on Recurring Basis | The following tables present the fair value hierarchy for the Company’s assets and liabilities measured at fair value on a recurring basis (in thousands): As of December 31, 2022 Level 1 Level 2 Level 3 Total Cash equivalents: Commercial paper $ — $ 16,455 $ — $ 16,455 Money market funds 6,580 — — 6,580 Total cash equivalents 6,580 16,455 — 23,035 Marketable securities: Asset-backed securities — 7,635 — 7,635 Certificates of deposit — 15,303 — 15,303 Commercial paper — 52,424 — 52,424 Corporate notes and bonds — 143,130 — 143,130 Sovereign bonds — 7,280 — 7,280 U.S. government and agency securities 438,739 — — 438,739 Total marketable securities 438,739 225,772 — 664,511 Total cash equivalents and marketable securities $ 445,319 $ 242,227 $ — $ 687,546 Liabilities: Contingent earn-out consideration liability $ — $ — $ 21,457 $ 21,457 Total contingent earn-out consideration liability $ — $ — $ 21,457 $ 21,457 As of March 31, 2022 Level 1 Level 2 Level 3 Total Cash equivalents: Commercial paper $ — $ 2,686 $ — $ 2,686 Money market funds 20,072 — — 20,072 Total cash equivalents 20,072 2,686 — 22,758 Marketable securities: Asset-backed securities — 7,740 — 7,740 Commercial paper — 9,383 — 9,383 Corporate notes and bonds — 128,104 — 128,104 Sovereign bonds — 8,436 — 8,436 U.S. government and agency securities 530,174 1,467 — 531,641 Total marketable securities 530,174 155,130 — 685,304 Total cash equivalents and marketable securities $ 550,246 $ 157,816 $ — $ 708,062 |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation | The following table summarizes the changes in the contingent earn-out consideration liability (in thousands): Nine Months Ended December 31, 2022 Beginning fair value $ — Additions in the period 21,134 Change in fair value 323 Ending fair value $ 21,457 |
Property and Equipment, Net (Ta
Property and Equipment, Net (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment, Net | Property and equipment, net consisted of the following (in thousands): December 31, 2022 March 31, 2022 Furniture and equipment $ 2,795 $ 336 Computers and software 745 769 Leasehold improvements 889 796 Internal-use software development costs 19,160 15,057 Total property and equipment 23,589 16,958 Less: accumulated depreciation and amortization (12,070) (8,470) Total property and equipment, net $ 11,519 $ 8,488 |
Accrued Expenses and Other Cu_2
Accrued Expenses and Other Current Liabilities (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Payables and Accruals [Abstract] | |
Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consisted of the following (in thousands): December 31, 2022 March 31, 2022 Accrued commissions $ 8,352 $ 6,653 Accrued payroll, bonus, and related expenses 8,435 8,015 Employee contributions under employee stock purchase plan 1,861 621 Rebate liabilities 2,328 4,933 Sales and other tax liabilities 1,568 785 Current portion of contingent earn-out consideration liability 5,832 — Other 4,775 4,263 Total accrued expenses and other current liabilities $ 33,151 $ 25,270 |
Business Combinations (Tables)
Business Combinations (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Purchase Consideration Allocation | The purchase consideration was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess recorded to goodwill as shown below. The purchase consideration allocation was as follows (in thousands): Assets acquired: Accounts receivable $ 447 Customer relationships 27,200 Software technology 820 Trademark 700 Total assets acquired $ 29,167 Liabilities assumed: Deferred revenue $ 2,925 Other liabilities 633 Net assets acquired, excluding goodwill 25,609 Goodwill $ 49,025 Total purchase consideration $ 74,634 |
Intangible Assets and Goodwill
Intangible Assets and Goodwill (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets, Net | Intangible assets, net consisted of the following (in thousands): December 31, 2022 March 31, 2022 Customer relationships $ 37,069 $ 9,869 Other intangibles 1,531 11 Total intangible assets 38,600 9,880 Less: accumulated amortization (5,566) (1,971) Total intangible assets, net $ 33,034 $ 7,909 |
Future Amortization Expense | As of December 31, 2022, future amortization expense is as follows (in thousands): Year Ending March 31, Amount Remainder of 2023 $ 1,198 2024 4,519 2025 4,245 2026 4,012 2027 4,010 2028 4,010 Thereafter 11,040 Total future amortization expense $ 33,034 |
Changes in Carrying Amount of Goodwill | The changes in the carrying amount of goodwill were as follows (in thousands): Nine Months Ended December 31, 2022 Balance, beginning of period $ 18,915 Goodwill acquired 49,025 Balance, end of period $ 67,940 |
Equity (Tables)
Equity (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Common Stock Reserved for Issuance | The Company has shares of common stock reserved for issuance as follows (in thousands): December 31, 2022 Common stock warrants 641 2010 Plan Options outstanding 21,223 2021 Plan Awards outstanding 2,022 Shares available for future grant 30,945 2021 ESPP 6,321 Options outstanding outside the plans 2,655 Total 63,807 |
Stock Option Activity | Stock option activities within the Plans as well as outside of the Plans were as follows: Number of Shares Weighted-Average Average Remaining Contractual Term Aggregate Intrinsic Value (in thousands) Balance, March 31, 2022 26,983 $ 4.15 7.63 $ 1,293,545 Options exercised (2,659) 2.77 Options forfeited or expired (446) 5.62 Balance, December 31, 2022 23,878 4.27 6.95 699,367 Vested and exercisable as of December 31, 2022 11,697 2.35 5.97 365,043 Vested and expected to vest as of December 31, 2022 22,476 4.19 6.89 660,023 |
Stock Options Valuation Assumptions | The fair value of each option on the date of grant was determined using the Black-Scholes option-pricing model with the assumptions set forth in the following table: Nine Months Ended December 31, 2021 Fair value of common stock $18.41 - $21.41 Volatility 46.5% - 47.0% Risk-free interest rate 0.77% - 1.02% Expected term (in years) 5.00 - 6.09 Expected dividend —% |
Restricted Stock Unit Activity | The following table summarizes RSU activity (in thousands, except per share information): Number of Shares Weighted- Unvested balance, March 31, 2022 534 $ 68.23 Granted 1,590 33.91 Vested (203) 54.44 Forfeited (92) 46.55 Unvested balance, December 31, 2022 1,829 41.01 |
Stock-Based Compensation Expense | Total stock-based compensation expense recognized in the condensed consolidated statements of operations was as follows (in thousands): Three Months Ended December 31, Nine Months Ended December 31, 2022 2021 2022 2021 Cost of revenue $ 2,695 $ 1,912 $ 7,209 $ 2,973 Research and development 4,002 2,035 9,416 4,864 Sales and marketing 4,856 2,681 11,912 5,575 General and administrative 2,431 3,206 6,306 8,221 Total stock-based compensation expense $ 13,984 $ 9,834 $ 34,843 $ 21,633 |
Net Income Per Share Attribut_2
Net Income Per Share Attributable to Common Stockholders (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Net Income Per Share, Basic and Diluted | The following table presents the reconciliation of the numerator and denominator for calculating basic and diluted net income per share (in thousands, except per share data): Three Months Ended December 31, Nine Months Ended December 31, 2022 2021 2022 2021 Numerator Net income $ 33,468 $ 55,647 $ 82,150 $ 118,057 Less: undistributed earnings attributable to participating securities — — — (21,866) Net income attributable to Class A and Class B common stockholders, basic and diluted $ 33,468 $ 55,647 $ 82,150 $ 96,191 Denominator Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic 192,805 188,372 192,963 154,289 Dilutive effect of stock options 19,118 27,762 20,491 28,377 Dilutive effect of common stock warrants 122 247 144 230 Dilutive effect of other share-based awards 20 15 58 9 Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted 212,065 216,396 213,656 182,905 Net income per share attributable to Class A and Class B common stockholders: Basic $ 0.17 $ 0.30 $ 0.43 $ 0.62 Diluted $ 0.16 $ 0.26 $ 0.38 $ 0.53 |
Antidilutive Securities Excluded from Computation of Net Income Per Share | Certain potentially dilutive securities have been excluded from the calculation of diluted net income per share during the applicable periods because their inclusion would have been anti-dilutive (in thousands): Three Months Ended December 31, Nine Months Ended December 31, 2022 2021 2022 2021 Other share-based awards 1,291 254 491 118 Common stock warrants 516 477 516 159 Total 1,807 731 1,007 277 |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Components of Lease Expense and Supplemental Cash Flow/Balance Sheet Information Related to Leases | The components of lease expense were as follows (in thousands): Three Months Ended December 31, Nine Months Ended December 31, 2022 2021 2022 2021 Operating lease cost $ 701 $ 285 $ 1,891 $ 846 Variable lease cost 15 25 187 74 Total lease cost $ 716 $ 310 $ 2,078 $ 920 Supplemental cash flow information related to leases was as follows (in thousands): Nine Months Ended December 31, 2022 2021 Cash paid for amounts included in measurement of lease liabilities—Operating cash flows $ 551 $ 782 Supplemental balance sheet information related to leases was as follows: December 31, 2022 March 31, 2022 Weighted-average remaining lease term (in years) 7.17 1.64 Weighted-average discount rate 4.18 % 3.95 % |
Maturities of Operating Lease Liabilities | Maturities of operating lease liabilities as of December 31, 2022 were as follows (in thousands): Remainder of 2023 $ 167 2024 2,238 2025 2,411 2026 2,458 2027 2,497 Thereafter 8,656 Total future lease payments $ 18,427 Less: imputed interest (2,788) Present value of lease liabilities $ 15,639 |
Description of Business (Detail
Description of Business (Details) $ / shares in Units, $ in Millions | 1 Months Ended | ||
Jun. 08, 2021 | Jun. 30, 2021 USD ($) $ / shares shares | Jun. 25, 2021 USD ($) | |
Subsidiary, Sale of Stock [Line Items] | |||
Conversion of stock, conversion ratio | 1 | ||
Capitalized deferred offering costs | $ | $ 5.5 | ||
Forward split ratio | 2 | ||
Redeemable Convertible Preferred Stock | |||
Subsidiary, Sale of Stock [Line Items] | |||
Conversion of stock, shares converted (in shares) | 76,286,618 | ||
Common Class B | |||
Subsidiary, Sale of Stock [Line Items] | |||
Conversion of stock, shares issued (in shares) | 76,286,618 | ||
Conversion of stock, conversion ratio | 1 | ||
Initial Public Offering, Including Over-Allotment Option | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of shares issued and sold in initial public offering | 22,505,750 | ||
Initial public offering price (in dollars per share) | $ / shares | $ 26 | ||
Aggregate net proceeds from initial public offering | $ | $ 548.5 | ||
Over-Allotment Option | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of shares issued and sold in initial public offering | 3,495,000 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net (Details) - Customer Concentration Risk | 9 Months Ended | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | Mar. 31, 2022 | |
Customer A | Revenue | |||
Concentration Risk [Line Items] | |||
Concentration risk | 10% | ||
Customer A | Accounts Receivable, Net | |||
Concentration Risk [Line Items] | |||
Concentration risk | 21% | ||
Customer B | Accounts Receivable, Net | |||
Concentration Risk [Line Items] | |||
Concentration risk | 10% |
Revenue Recognition - Narrative
Revenue Recognition - Narrative (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Mar. 31, 2022 | |
Disaggregation of Revenue [Line Items] | |||||
Unbilled revenue | $ 2,800,000 | $ 2,800,000 | $ 1,400,000 | ||
Revenue recognized from deferred revenue | 65,600,000 | $ 58,000,000 | 81,800,000 | $ 79,600,000 | |
Capitalized contract acquisition costs | 4,100,000 | 3,700,000 | 6,400,000 | 6,700,000 | |
Deferred contract costs, amortization | 1,500,000 | 1,700,000 | 6,357,000 | 7,366,000 | |
Deferred contract costs, impairment losses | $ 0 | $ 0 | $ 0 | $ 0 | |
Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts | Minimum | |||||
Disaggregation of Revenue [Line Items] | |||||
Deferred contract costs, amortization period | 7 months | 7 months | |||
Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts | Maximum | |||||
Disaggregation of Revenue [Line Items] | |||||
Deferred contract costs, amortization period | 13 months | 13 months | |||
Sales Commissions For Subscriptions Of New And Expansion Hiring Solutions Contracts | |||||
Disaggregation of Revenue [Line Items] | |||||
Deferred contract costs, amortization period | 4 years | 4 years | |||
Subscription, Marketing Solutions | |||||
Disaggregation of Revenue [Line Items] | |||||
Contractual term | 12 months | ||||
Contract cancellation, notice period | 30 days | ||||
Subscription, Hiring Solutions | |||||
Disaggregation of Revenue [Line Items] | |||||
Contractual term | 12 months |
Revenue Recognition - Disaggreg
Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disaggregation of Revenue [Line Items] | ||||
Revenue | $ 115,262 | $ 97,876 | $ 308,086 | $ 249,895 |
Subscription | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 107,508 | 91,066 | 286,556 | 233,510 |
Other | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | $ 7,754 | $ 6,810 | $ 21,530 | $ 16,385 |
Investments - Cost, Gross Unrea
Investments - Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Mar. 31, 2022 | Dec. 31, 2021 |
Debt Securities, Available-for-sale [Line Items] | |||
Gross Unrealized Gains | $ 10 | $ 0 | |
Gross Unrealized Losses | (25,125) | (20,494) | |
Fair Value | 680,966 | ||
Cost or Amortized Cost, money market funds | 136,454 | 112,809 | |
Cost or Amortized Cost, cash equivalents and marketable securities | 712,661 | 728,556 | |
Fair Value, cash equivalents and marketable securities | 687,546 | 708,062 | |
Cash and Cash Equivalents | |||
Debt Securities, Available-for-sale [Line Items] | |||
Gross Unrealized Gains | 0 | 0 | |
Gross Unrealized Losses | (4) | 0 | |
Fair Value | 23,035 | ||
Cost or Amortized Cost, cash equivalents and marketable securities | 23,039 | 22,758 | |
Fair Value, cash equivalents and marketable securities | 22,758 | ||
Marketable Securities | |||
Debt Securities, Available-for-sale [Line Items] | |||
Cost or Amortized Cost | 689,622 | 705,798 | |
Gross Unrealized Gains | 10 | 0 | |
Gross Unrealized Losses | (25,121) | (20,494) | $ (5,400) |
Fair Value | 664,511 | 685,304 | |
Commercial paper | Cash and Cash Equivalents | |||
Debt Securities, Available-for-sale [Line Items] | |||
Cost or Amortized Cost | 16,459 | 2,686 | |
Gross Unrealized Gains | 0 | 0 | |
Gross Unrealized Losses | (4) | 0 | |
Fair Value | 16,455 | 2,686 | |
Money market funds | |||
Debt Securities, Available-for-sale [Line Items] | |||
Cost or Amortized Cost, money market funds | 6,580 | 20,072 | |
Fair Value, money market funds | 6,580 | 20,072 | |
Asset-backed securities | Marketable Securities | |||
Debt Securities, Available-for-sale [Line Items] | |||
Cost or Amortized Cost | 7,754 | 7,791 | |
Gross Unrealized Gains | 0 | 0 | |
Gross Unrealized Losses | (119) | (51) | |
Fair Value | 7,635 | 7,740 | |
Certificates of deposit | Marketable Securities | |||
Debt Securities, Available-for-sale [Line Items] | |||
Cost or Amortized Cost | 15,414 | ||
Gross Unrealized Gains | 0 | ||
Gross Unrealized Losses | (111) | ||
Fair Value | 15,303 | ||
Commercial paper | Marketable Securities | |||
Debt Securities, Available-for-sale [Line Items] | |||
Cost or Amortized Cost | 52,531 | 9,436 | |
Gross Unrealized Gains | 5 | 0 | |
Gross Unrealized Losses | (112) | (53) | |
Fair Value | 52,424 | 9,383 | |
Corporate notes and bonds | Marketable Securities | |||
Debt Securities, Available-for-sale [Line Items] | |||
Cost or Amortized Cost | 144,640 | 129,900 | |
Gross Unrealized Gains | 5 | 0 | |
Gross Unrealized Losses | (1,515) | (1,796) | |
Fair Value | 143,130 | 128,104 | |
Sovereign bonds | Marketable Securities | |||
Debt Securities, Available-for-sale [Line Items] | |||
Cost or Amortized Cost | 7,743 | 8,770 | |
Gross Unrealized Gains | 0 | 0 | |
Gross Unrealized Losses | (463) | (334) | |
Fair Value | 7,280 | 8,436 | |
U.S. government and agency securities | Marketable Securities | |||
Debt Securities, Available-for-sale [Line Items] | |||
Cost or Amortized Cost | 461,540 | 549,901 | |
Gross Unrealized Gains | 0 | 0 | |
Gross Unrealized Losses | (22,801) | (18,260) | |
Fair Value | $ 438,739 | $ 531,641 |
Investments - Contractual Matur
Investments - Contractual Maturities of Available-For-Sale Debt Securities (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Investments, Debt and Equity Securities [Abstract] | |
Due within one year | $ 309,888 |
Due in one year to three years | 371,078 |
Total | $ 680,966 |
Investments - Narrative (Detail
Investments - Narrative (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Mar. 31, 2022 | |
Debt Securities, Available-for-sale [Line Items] | |||||
Accrued interest | $ 2,200,000 | $ 2,200,000 | $ 2,100,000 | ||
Unrealized losses of debt securities | 25,125,000 | 25,125,000 | 20,494,000 | ||
Impairment on debt securities | 0 | 0 | |||
Debt securities credit losses | 0 | $ 0 | 0 | $ 0 | |
Fair value of debt securities which no credit losses were recognized | 649,500,000 | 678,800,000 | 649,500,000 | 678,800,000 | |
Impairment on debt securities during period | 0 | 0 | |||
Marketable Securities | |||||
Debt Securities, Available-for-sale [Line Items] | |||||
Unrealized losses of debt securities | $ 25,121,000 | $ 5,400,000 | $ 25,121,000 | $ 5,400,000 | $ 20,494,000 |
Fair Value Measurements - Asset
Fair Value Measurements - Assets and Liabilities at Fair Value (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Mar. 31, 2022 |
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | $ 680,966 | |
Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 23,035 | |
Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 664,511 | $ 685,304 |
Commercial paper | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 16,455 | 2,686 |
Asset-backed securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 7,635 | 7,740 |
Certificates of deposit | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 15,303 | |
Commercial paper | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 52,424 | 9,383 |
Corporate notes and bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 143,130 | 128,104 |
Sovereign bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 7,280 | 8,436 |
U.S. government and agency securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 438,739 | 531,641 |
Fair Value, Recurring | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 687,546 | 708,062 |
Liabilities: | ||
Contingent earn-out consideration liability | 21,457 | |
Total contingent earn-out consideration liability | 21,457 | |
Fair Value, Recurring | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 23,035 | 22,758 |
Fair Value, Recurring | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 664,511 | 685,304 |
Fair Value, Recurring | Commercial paper | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 16,455 | 2,686 |
Fair Value, Recurring | Money market funds | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 6,580 | 20,072 |
Fair Value, Recurring | Asset-backed securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 7,635 | 7,740 |
Fair Value, Recurring | Certificates of deposit | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 15,303 | |
Fair Value, Recurring | Commercial paper | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 52,424 | 9,383 |
Fair Value, Recurring | Corporate notes and bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 143,130 | 128,104 |
Fair Value, Recurring | Sovereign bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 7,280 | 8,436 |
Fair Value, Recurring | U.S. government and agency securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 438,739 | 531,641 |
Level 1 | Fair Value, Recurring | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 445,319 | 550,246 |
Liabilities: | ||
Contingent earn-out consideration liability | 0 | |
Total contingent earn-out consideration liability | 0 | |
Level 1 | Fair Value, Recurring | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 6,580 | 20,072 |
Level 1 | Fair Value, Recurring | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 438,739 | 530,174 |
Level 1 | Fair Value, Recurring | Commercial paper | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 1 | Fair Value, Recurring | Money market funds | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 6,580 | 20,072 |
Level 1 | Fair Value, Recurring | Asset-backed securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 1 | Fair Value, Recurring | Certificates of deposit | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | |
Level 1 | Fair Value, Recurring | Commercial paper | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 1 | Fair Value, Recurring | Corporate notes and bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 1 | Fair Value, Recurring | Sovereign bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 1 | Fair Value, Recurring | U.S. government and agency securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 438,739 | 530,174 |
Level 2 | Fair Value, Recurring | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 242,227 | 157,816 |
Liabilities: | ||
Contingent earn-out consideration liability | 0 | |
Total contingent earn-out consideration liability | 0 | |
Level 2 | Fair Value, Recurring | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 16,455 | 2,686 |
Level 2 | Fair Value, Recurring | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 225,772 | 155,130 |
Level 2 | Fair Value, Recurring | Commercial paper | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 16,455 | 2,686 |
Level 2 | Fair Value, Recurring | Money market funds | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 2 | Fair Value, Recurring | Asset-backed securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 7,635 | 7,740 |
Level 2 | Fair Value, Recurring | Certificates of deposit | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 15,303 | |
Level 2 | Fair Value, Recurring | Commercial paper | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 52,424 | 9,383 |
Level 2 | Fair Value, Recurring | Corporate notes and bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 143,130 | 128,104 |
Level 2 | Fair Value, Recurring | Sovereign bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 7,280 | 8,436 |
Level 2 | Fair Value, Recurring | U.S. government and agency securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 1,467 |
Level 3 | Fair Value, Recurring | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Liabilities: | ||
Contingent earn-out consideration liability | 21,457 | |
Total contingent earn-out consideration liability | 21,457 | |
Level 3 | Fair Value, Recurring | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 3 | Fair Value, Recurring | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 3 | Fair Value, Recurring | Commercial paper | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 3 | Fair Value, Recurring | Money market funds | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 3 | Fair Value, Recurring | Asset-backed securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 3 | Fair Value, Recurring | Certificates of deposit | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | |
Level 3 | Fair Value, Recurring | Commercial paper | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 3 | Fair Value, Recurring | Corporate notes and bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 3 | Fair Value, Recurring | Sovereign bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 3 | Fair Value, Recurring | U.S. government and agency securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | $ 0 | $ 0 |
Fair Value Measurements - Conti
Fair Value Measurements - Contingent Earn-Out Consideration Liability (Details) $ in Thousands | 9 Months Ended |
Dec. 31, 2022 USD ($) | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Beginning fair value | $ 0 |
Additions in the period | 21,134 |
Change in fair value | 323 |
Ending fair value | $ 21,457 |
Property and Equipment, Net - T
Property and Equipment, Net - Total Property and Equipment, Net (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Mar. 31, 2022 |
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | $ 23,589 | $ 16,958 |
Less: accumulated depreciation and amortization | (12,070) | (8,470) |
Total property and equipment, net | 11,519 | 8,488 |
Furniture and equipment | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 2,795 | 336 |
Computers and software | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 745 | 769 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 889 | 796 |
Internal-use software development costs | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | $ 19,160 | $ 15,057 |
Property and Equipment, Net - N
Property and Equipment, Net - Narrative (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Property, Plant and Equipment [Abstract] | ||||
Depreciation and amortization expense | $ 1,400,000 | $ 1,100,000 | $ 4,000,000 | $ 2,800,000 |
Amortization of internal-use software development costs | 1,200,000 | 1,000,000 | 3,500,000 | 2,500,000 |
Capitalized internal-use software development costs | 1,200,000 | 1,200,000 | 4,100,000 | 3,100,000 |
Impairment charges | $ 0 | $ 0 | $ 0 | $ 0 |
Accrued Expenses and Other Cu_3
Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Mar. 31, 2022 |
Payables and Accruals [Abstract] | ||
Accrued commissions | $ 8,352 | $ 6,653 |
Accrued payroll, bonus, and related expenses | 8,435 | 8,015 |
Employee contributions under employee stock purchase plan | 1,861 | 621 |
Rebate liabilities | 2,328 | 4,933 |
Sales and other tax liabilities | 1,568 | 785 |
Current portion of contingent earn-out consideration liability | 5,832 | 0 |
Other | 4,775 | 4,263 |
Total accrued expenses and other current liabilities | $ 33,151 | $ 25,270 |
Business Combinations - Narrati
Business Combinations - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions | 1 Months Ended | 9 Months Ended | |
Apr. 01, 2022 | May 31, 2022 | Dec. 31, 2022 | |
Restricted Stock Units (RSUs) | |||
Business Acquisition [Line Items] | |||
Other than options granted in period (in shares) | 1,590,000 | ||
Granted (in dollars per share) | $ 33.91 | ||
Award vesting period | 4 years | ||
AMiON | |||
Business Acquisition [Line Items] | |||
Consideration transferred | $ 74.6 | ||
Payments to acquire businesses | 53.5 | ||
Contingent earn-out consideration liability | 21.1 | ||
Contingent earn-out consideration (up to) | 24 | ||
Contingent earn-out consideration liability, minimum guarantee | 4 | ||
Contingent earn-out consideration liability, subject to performance | $ 20 | ||
Contingent earnout consideration performance period | 4 years | ||
Contingent earnout consideration payable period | 4 years | ||
Award vesting period | 4 years | ||
AMiON | Restricted Stock Units (RSUs) | |||
Business Acquisition [Line Items] | |||
Other than options granted in period (in shares) | 93,458 | ||
Granted (in dollars per share) | $ 32.99 | ||
AMiON | Customer relationships | |||
Business Acquisition [Line Items] | |||
Finite-lived intangibles, useful life | 9 years | ||
AMiON | Trademark | |||
Business Acquisition [Line Items] | |||
Finite-lived intangibles, useful life | 3 years | ||
AMiON | Software technology | |||
Business Acquisition [Line Items] | |||
Finite-lived intangibles, useful life | 18 months |
Business Combinations - Purchas
Business Combinations - Purchase Consideration Allocation (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Apr. 01, 2022 | Mar. 31, 2022 |
Liabilities assumed: | |||
Goodwill | $ 67,940 | $ 18,915 | |
AMiON | |||
Assets acquired: | |||
Accounts receivable | $ 447 | ||
Total assets acquired | 29,167 | ||
Liabilities assumed: | |||
Deferred revenue | 2,925 | ||
Other liabilities | 633 | ||
Net assets acquired, excluding goodwill | 25,609 | ||
Goodwill | 49,025 | ||
Total purchase consideration | 74,634 | ||
AMiON | Customer relationships | |||
Assets acquired: | |||
Finite-lived intangibles | 27,200 | ||
AMiON | Software technology | |||
Assets acquired: | |||
Finite-lived intangibles | 820 | ||
AMiON | Trademark | |||
Assets acquired: | |||
Finite-lived intangibles | $ 700 |
Intangible Assets and Goodwil_2
Intangible Assets and Goodwill - Intangible Assets, Net (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Mar. 31, 2022 |
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | $ 38,600 | $ 9,880 |
Less: accumulated amortization | (5,566) | (1,971) |
Intangible assets, net | 33,034 | 7,909 |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | 37,069 | 9,869 |
Other intangibles | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | $ 1,531 | $ 11 |
Intangible Assets and Goodwil_3
Intangible Assets and Goodwill - Narrative (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||||
Amortization of intangible assets | $ 1,200,000 | $ 300,000 | $ 3,600,000 | $ 900,000 |
Impairment of intangible assets | 0 | 0 | 0 | 0 |
Goodwill impairment | $ 0 | $ 0 | $ 0 | $ 0 |
Intangible Assets and Goodwil_4
Intangible Assets and Goodwill - Future Amortization Expense (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Mar. 31, 2022 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Remainder of 2023 | $ 1,198 | |
2024 | 4,519 | |
2025 | 4,245 | |
2026 | 4,012 | |
2027 | 4,010 | |
2028 | 4,010 | |
Thereafter | 11,040 | |
Intangible assets, net | $ 33,034 | $ 7,909 |
Intangible Assets and Goodwil_5
Intangible Assets and Goodwill - Changes in Carrying Amount of Goodwill (Details) $ in Thousands | 9 Months Ended |
Dec. 31, 2022 USD ($) | |
Goodwill [Roll Forward] | |
Balance, beginning of period | $ 18,915 |
Goodwill acquired | 49,025 |
Balance, end of period | $ 67,940 |
Equity - Narrative (Details)
Equity - Narrative (Details) $ / shares in Units, $ in Thousands | 1 Months Ended | 3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||
Oct. 28, 2022 USD ($) | May 27, 2022 shares | Jun. 08, 2021 vote $ / shares shares | Oct. 31, 2021 USD ($) $ / shares Year shares | Jun. 30, 2021 $ / shares shares | Dec. 31, 2022 USD ($) equity_incentive_plan $ / shares shares | Dec. 31, 2021 USD ($) | Sep. 30, 2022 USD ($) shares | Dec. 31, 2022 USD ($) equity_incentive_plan $ / shares shares | Dec. 31, 2021 USD ($) $ / shares | Mar. 31, 2018 shares | May 12, 2022 USD ($) | Mar. 31, 2022 $ / shares shares | Mar. 31, 2017 $ / shares shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Preferred stock, authorized (in shares) | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | ||||||||||
Preferred stock, par value (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||
Preferred stock, issued (in shares) | 0 | 0 | 0 | |||||||||||
Preferred stock, outstanding (in shares) | 0 | 0 | 0 | |||||||||||
Common stock, authorized (in shares) | 1,500,000,000 | 1,500,000,000 | 1,500,000,000 | |||||||||||
Common stock, par value (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | |||||||||||
Conversion of stock, conversion ratio | 1 | |||||||||||||
Common stock, outstanding (in shares) | 193,252,000 | 193,252,000 | 192,398,000 | |||||||||||
Stock repurchase program, authorized amount | $ | $ 70,000 | $ 70,000 | ||||||||||||
Stock repurchase program, period in force | 12 months | |||||||||||||
Repurchase and retirement of common stock (in shares) | 2,150,982 | |||||||||||||
Repurchase and retirement of common stock | $ | $ 70,000 | $ 70,042 | $ 2,698 | |||||||||||
Number of shares called by warrants | 641,000 | 641,000 | ||||||||||||
Stock based compensation expense | $ | $ 13,984 | $ 9,834 | $ 34,843 | 21,633 | ||||||||||
Number of equity incentive plans | equity_incentive_plan | 3 | 3 | ||||||||||||
Options outstanding in period (in shares) | 23,878,000 | 23,878,000 | 26,983,000 | |||||||||||
Aggregate intrinsic value of options | $ | $ 85,300 | $ 406,900 | ||||||||||||
Unamortized compensation expense, option | $ | $ 41,200 | $ 41,200 | ||||||||||||
Weighted-average grant-date fair value of options granted (in dollars per share) | $ / shares | $ 10.73 | |||||||||||||
Share-based Payment Arrangement, Option | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Unamortized compensation expense, weighted average period of recognition | 2 years 11 months 19 days | |||||||||||||
Award vesting period | 4 years | |||||||||||||
Expiration period from the date of grant | 10 years | |||||||||||||
Restricted Stock Units (RSUs) | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Unamortized compensation expense excluding option | $ | $ 57,000 | $ 57,000 | ||||||||||||
Unamortized compensation expense, weighted average period of recognition | 3 years 3 months | |||||||||||||
Award vesting period | 4 years | |||||||||||||
Total fair value of non-option instrument | $ | $ 7,000 | $ 1,400 | ||||||||||||
Outstanding unvested (in shares) | 1,829,000 | 1,829,000 | 534,000 | |||||||||||
Performance-Based Restricted Stock Units | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Unamortized compensation expense excluding option | $ | $ 1,700 | $ 1,700 | ||||||||||||
Outstanding unvested (in shares) | 193,455 | 193,455 | ||||||||||||
Outstanding unvested, probable to vest (in shares) | 73,377 | 73,377 | ||||||||||||
2021 Plan | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Number of additional shares authorized | 9,619,921 | |||||||||||||
ESPP | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Number of additional shares authorized | 1,923,984 | |||||||||||||
Approved by Board of Directors, Outside of Plans | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Options granted in period (in shares) | 4,682,582 | |||||||||||||
Options exercised (in shares) | 2,027,917 | 2,027,917 | ||||||||||||
Options outstanding in period (in shares) | 2,654,665 | 2,654,665 | ||||||||||||
Contract With U.S. News & World Report, L.P. | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Number of shares called by warrants | 250,000 | |||||||||||||
Exercise price called by warrants (in dollars per share) | $ / shares | $ 0.72 | |||||||||||||
Warrant outstanding, term | 10 years | |||||||||||||
Warrants exercised in period (in shares) | 125,000 | |||||||||||||
Warrants exercised in period , intrinsic value | $ | $ 4,000 | |||||||||||||
Warrant outstanding (in shares) | 125,000 | 125,000 | ||||||||||||
U.S. News Warrant | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Number of shares called by warrants | 516,000 | |||||||||||||
Exercise price called by warrants (in dollars per share) | $ / shares | $ 12.56 | |||||||||||||
Warrant outstanding, term | 10 years | |||||||||||||
Warrants outstanding, vesting period | 6 years 5 months 23 days | |||||||||||||
Fair value of warrant | $ | $ 34,700 | |||||||||||||
Stock based compensation expense | $ | $ 4,000 | |||||||||||||
Unamortized compensation expense excluding option | $ | $ 28,100 | $ 28,100 | ||||||||||||
Unamortized compensation expense, weighted average period of recognition | 5 years 3 months | |||||||||||||
U.S. News Warrant | Share-Based Payment Arrangement, Subsequent to Tranche One | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Warrants outstanding, vesting period | 6 years | |||||||||||||
U.S. News Warrant | Measurement Input, Share Price | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Warrant, measurement input | $ / shares | 76.50 | |||||||||||||
U.S. News Warrant | Measurement Input, Price Volatility | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Warrant, measurement input | 0.469 | |||||||||||||
U.S. News Warrant | Measurement Input, Risk Free Interest Rate | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Warrant, measurement input | 0.0161 | |||||||||||||
U.S. News Warrant | Measurement Input, Expected Term | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Warrant, measurement input | Year | 10 | |||||||||||||
U.S. News Warrant | Measurement Input, Expected Dividend Rate | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Warrant, measurement input | 0 | |||||||||||||
Class A and Class B Common Stock | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Conversion of stock (in shares) | 85,523,836 | |||||||||||||
Common Class A | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Common stock, authorized (in shares) | 1,000,000,000 | |||||||||||||
Common stock, par value (in dollars per share) | $ / shares | $ 0.001 | |||||||||||||
Common stock, number of votes per share | vote | 1 | |||||||||||||
Common stock, outstanding (in shares) | 118,355,360 | 118,355,360 | ||||||||||||
Common Class B | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||
Common stock, authorized (in shares) | 500,000,000 | |||||||||||||
Common stock, par value (in dollars per share) | $ / shares | $ 0.001 | |||||||||||||
Common stock, number of votes per share | vote | 10 | |||||||||||||
Conversion of stock, conversion ratio | 1 | |||||||||||||
Common stock, outstanding (in shares) | 74,896,344 | 74,896,344 |
Equity - Common Stock Reserved
Equity - Common Stock Reserved for Issuance (Details) - shares | Dec. 31, 2022 | Mar. 31, 2022 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Common stock warrants (in shares) | 641,000 | |
Options outstanding (in shares) | 23,878,000 | 26,983,000 |
Total (in shares) | 63,807,000 | |
2010 Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Options outstanding (in shares) | 21,223,000 | |
2021 Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Shares available for future grant (in shares) | 30,945,000 | |
Units outstanding (in shares) | 2,022,000 | |
2021 ESPP | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Shares available for future grant (in shares) | 6,321,000 | |
Options outstanding outside the plans | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Options outstanding (in shares) | 2,654,665 |
Equity - Stock Option Activity
Equity - Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands | 9 Months Ended | 12 Months Ended |
Dec. 31, 2022 USD ($) $ / shares shares | Mar. 31, 2022 USD ($) $ / shares shares | |
Number of Shares (in thousands) | ||
Beginning balance (in shares) | shares | 26,983 | |
Options exercised (in shares) | shares | (2,659) | |
Options forfeited or expired (in shares) | shares | (446) | |
Ending balance (in shares) | shares | 23,878 | 26,983 |
Vested and exercisable, at end of period (in shares) | shares | 11,697 | |
Vested and expected to vest, at end of period (in shares) | shares | 22,476 | |
Weighted-Average Exercise Price | ||
Beginning balance (in dollars per share) | $ / shares | $ 4.15 | |
Exercised (in dollars per share) | $ / shares | 2.77 | |
Forfeited or expired (in dollars per share) | $ / shares | 5.62 | |
Ending balance (in dollars per share) | $ / shares | 4.27 | $ 4.15 |
Weighted average exercise price, vested and exercisable at period end (in dollars per share) | $ / shares | 2.35 | |
Weighted average exercise price, vested and expected to vest at period end (in dollars per share) | $ / shares | $ 4.19 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ||
Average remaining contractual term, outstanding | 6 years 11 months 12 days | 7 years 7 months 17 days |
Average remaining contractual term, vested and exercisable at period end | 5 years 11 months 19 days | |
Average remaining contractual term, vested and expected to vest at period end | 6 years 10 months 20 days | |
Aggregate intrinsic value, outstanding | $ | $ 699,367 | $ 1,293,545 |
Aggregate intrinsic value, vested and exercisable at period end | $ | 365,043 | |
Aggregate intrinsic value, vested and expected to vest at period end | $ | $ 660,023 |
Equity - Stock Options Valuatio
Equity - Stock Options Valuation Assumptions (Details) - Share-based Payment Arrangement, Option | 9 Months Ended |
Dec. 31, 2021 $ / shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Expected volatility, minimum | 46.50% |
Expected volatility, maximum | 47% |
Risk free interest rate, minimum | 0.77% |
Risk free interest rate, maximum | 1.02% |
Expected dividend | 0% |
Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Fair value of common stock (in dollars per share) | $ 18.41 |
Expected term (in years) | 5 years |
Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Fair value of common stock (in dollars per share) | $ 21.41 |
Expected term (in years) | 6 years 1 month 2 days |
Equity - Restricted Stock Unit
Equity - Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) shares in Thousands | 9 Months Ended |
Dec. 31, 2022 $ / shares shares | |
Number of Shares | |
Beginning balance (in shares) | shares | 534 |
Granted (in shares) | shares | 1,590 |
Vested (in shares) | shares | (203) |
Forfeited (in shares) | shares | (92) |
Ending balance (in shares) | shares | 1,829 |
Weighted- Average Grant Date Fair Value | |
Beginning balance (in dollars per share) | $ / shares | $ 68.23 |
Granted (in dollars per share) | $ / shares | 33.91 |
Vested (in dollars per share) | $ / shares | 54.44 |
Forfeited (in dollars per share) | $ / shares | 46.55 |
Ending balance (in dollars per share) | $ / shares | $ 41.01 |
Equity - Stock-Based Compensati
Equity - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Stock based compensation expense | $ 13,984 | $ 9,834 | $ 34,843 | $ 21,633 |
Cost of revenue | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Stock based compensation expense | 2,695 | 1,912 | 7,209 | 2,973 |
Research and development | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Stock based compensation expense | 4,002 | 2,035 | 9,416 | 4,864 |
Sales and marketing | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Stock based compensation expense | 4,856 | 2,681 | 11,912 | 5,575 |
General and administrative | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Stock based compensation expense | $ 2,431 | $ 3,206 | $ 6,306 | $ 8,221 |
Net Income Per Share Attribut_3
Net Income Per Share Attributable to Common Stockholders - Net Income Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Numerator | ||||
Net income | $ 33,468 | $ 55,647 | $ 82,150 | $ 118,057 |
Less: undistributed earnings attributable to participating securities, diluted | 0 | 0 | 0 | (21,866) |
Less: undistributed earnings attributable to participating securities, basic | 0 | 0 | 0 | (21,866) |
Net income attributable to Class A and Class B common stockholders, basic | 33,468 | 55,647 | 82,150 | 96,191 |
Net income attributable to Class A and Class B common stockholders, diluted | $ 33,468 | $ 55,647 | $ 82,150 | $ 96,191 |
Denominator | ||||
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic (in shares) | 192,805 | 188,372 | 192,963 | 154,289 |
Dilutive effect of common stock warrants (in shares) | 122 | 247 | 144 | 230 |
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted (in shares) | 212,065 | 216,396 | 213,656 | 182,905 |
Net income per share attributable to Class A and Class B common stockholders: | ||||
Basic (in dollars per share) | $ 0.17 | $ 0.30 | $ 0.43 | $ 0.62 |
Diluted (in dollars per share) | $ 0.16 | $ 0.26 | $ 0.38 | $ 0.53 |
Share-based Payment Arrangement, Option | ||||
Denominator | ||||
Dilutive effect of share-based payment (in shares) | 19,118 | 27,762 | 20,491 | 28,377 |
Other share-based awards | ||||
Denominator | ||||
Dilutive effect of share-based payment (in shares) | 20 | 15 | 58 | 9 |
Net Income Per Share Attribut_4
Net Income Per Share Attributable to Common Stockholders - Antidilutive Securities Excluded from Computation of Net Income Per Share (Details) - shares shares in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation of net income per share (in shares) | 1,807 | 731 | 1,007 | 277 |
Other share-based awards | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation of net income per share (in shares) | 1,291 | 254 | 491 | 118 |
Common stock warrants | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation of net income per share (in shares) | 516 | 477 | 516 | 159 |
Commitments and Contingencies (
Commitments and Contingencies (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Oct. 08, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Other Commitments [Line Items] | |||||
Partnership agreement, extension period | 6 years | ||||
Partnerships agreement, period before termination is permitted | 3 years | ||||
Partnership agreement, noncancelable period | 2 years | ||||
Partnership agreement, revenue guarantee during noncancelable period | $ 6,600,000 | ||||
Hosting arrangement period | 3 years | ||||
Hosting arrangement annual commitment | $ 5,200,000 | $ 5,200,000 | |||
Hosting arrangement remaining commitment | 10,400,000 | 10,400,000 | |||
Loss contingency | 0 | $ 0 | 0 | $ 0 | |
Minimum | |||||
Other Commitments [Line Items] | |||||
Partnership agreement, annual revenue guarantee to partnering company | 3,000,000 | 3,000,000 | |||
Maximum | |||||
Other Commitments [Line Items] | |||||
Partnership agreement, annual revenue guarantee to partnering company | $ 6,200,000 | $ 6,200,000 |
Leases - Components of Lease Ex
Leases - Components of Lease Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Leases [Abstract] | ||||
Operating lease cost | $ 701 | $ 285 | $ 1,891 | $ 846 |
Variable lease cost | 15 | 25 | 187 | 74 |
Total lease cost | $ 716 | $ 310 | $ 2,078 | $ 920 |
Leases - Supplemental Cash Flow
Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Leases [Abstract] | ||
Cash paid for amounts included in measurement of lease liabilities—Operating cash flows | $ 551 | $ 782 |
Leases - Supplemental Balance S
Leases - Supplemental Balance Sheet Information (Details) | Dec. 31, 2022 | Mar. 31, 2022 |
Leases [Abstract] | ||
Weighted-average remaining lease term (in years) | 7 years 2 months 1 day | 1 year 7 months 20 days |
Weighted-average discount rate | 4.18% | 3.95% |
Leases - Maturities of Lease Li
Leases - Maturities of Lease Liabilities (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Leases [Abstract] | |
Remainder of 2023 | $ 167 |
2024 | 2,238 |
2025 | 2,411 |
2026 | 2,458 |
2027 | 2,497 |
Thereafter | 8,656 |
Total future lease payments | 18,427 |
Less: imputed interest | (2,788) |
Present value of lease liabilities | $ 15,639 |
Leases - Narrative (Details)
Leases - Narrative (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 |
Lessee, Lease, Description [Line Items] | ||||
Operating lease right-of-use assets | $ 14,357 | $ 1,087 | ||
Present value of lease liabilities | $ 15,639 | |||
Portion of Office Space | ||||
Lessee, Lease, Description [Line Items] | ||||
Operating lease, term of contract | 8 years | |||
Operating lease right-of-use assets | $ 10,900 | |||
Present value of lease liabilities | $ 10,900 | |||
Remaining Portion of Office Space | ||||
Lessee, Lease, Description [Line Items] | ||||
Operating lease, term of contract | 8 years | |||
Operating lease right-of-use assets | $ 3,900 | |||
Present value of lease liabilities | $ 3,900 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Mar. 31, 2022 | |
Income Tax Disclosure [Abstract] | |||||
Effective tax rate | 18.30% | (55.40%) | 14.80% | (37.10%) | |
Unrecognized tax benefits | $ 7.5 | $ 7.5 | $ 6.2 | ||
Unrecognized tax benefits that would impact effective tax rate | $ 5.2 | $ 5.2 |
Segment and Geographic Inform_2
Segment and Geographic Information (Details) | 9 Months Ended |
Dec. 31, 2022 segment | |
Segment Reporting [Abstract] | |
Number of operating segments | 1 |
Number of reportable segments | 1 |